Psyllid ID: psy9686


Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------77
MKPIKYTRPCLDCRGSRDHGIFQINDKYWCTASGPAGKECHAKCSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTYHYCNTNSKVSTYYSSSFNCLVLICFLSCILKSSTLNSLRSLGGGFTGFHSGQMSGLARYGGVSPSTILCIKVSTLSRILIYIFKIWCKTHMALSRLTPRYLHVDTYSKISDPIFTDRFRDRIWFLALLINLSSFFVSVPLMLISLEIFKELNGLNFRIKVFSHCRNEGRPQSAMHFSPIAACLLVLVYCTLLPRQIEGKRFGACELAKFLVRQRGIARRDVPTWVCIATKESNRNSNARSPKNGNGSRDHGIFQINDKYWCTASGPAGKECHAKCSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTYHYCNTNSKVSTYDHADDMGEVSACACYMHVNYLGSSLKLETVLMSSEKIFISYSSTHHISKMANKFKFNLFKDHADDMGTCTWEKLALALAKKKTHPMFGKLAHFESQELFLSSALKKPGAAALGGCAGRPCRNNGTCTPVSGGVVNFTCTCPSGGQGQSGLEITPVYLWLMKLKTLVMVQYYFRRKSTSPHKSRGQGQSGLEITPVYLWLMKMKTLVMVQYYLQQNISPLKDGNLSFYCNCTEDFTGEYCQFENSAACVTLNPCQNNATCVASPGDKQITCLCLKGGTVSSEYCQFENSAACVTLNPCQNNATCVASPGDKQITCLCLKGFEGPHRELPVESVDEPPSEDETSVDLQLGSQANSYNWAHMLIVTTGS
cccccccccccccccccccccEEEccEEEEccccccccccccccccccccccccccEEEEEEcccccccccccccEEEEEccccccccccHHHccccccHHHHHHHHHHHcccccccccccccccccccccccccccccccccccEEEEEEEcHHHHHHHHHHHHHHHHHHHHHcccccEEEEEccccccccccHHHHHHHHHHHHHHHHccccEEEHHHHHHHHHHHHHccccEEEEEEEccccccccccccccccHHHHHHHHHHHHHccccccccccccHHHHHHHHHHHHcccccccccEEEEEEccccccccccccccccccccEEEEEEccEEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcccccccccEEEEcccccccccccccccccccccccccccEEcccccccccccccccccccccEEEccccccccccccccccccccccccccEEcccccEEEEccccccccccccccccccccccccccccEEEcccccccEEEEccccccccccccccccccccccccccccccEEEcccccccEEEEccccccccccccccccccccccccccccccccccEEEcccccEEEEccccc
cccEEEcccccccccEEEEccccEEcccccEccccccccccEEHHHHHccccHHHHHHHHHHHHHHccccccccHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHHHHHcHHHHHHHcccccccccccccccHHHcccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHccccEEEEccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHHHHHcHHccHccHHHHHHHHHHHccccHHHHHHHHHHHHHHcccEcccEcccccccccEEccccEEccccEEccccccccccEEHHHHHccccHHHHHHHHHHHHHHcccccccHHHHHHHHHHcccccHHHHHHccccccccHHccccccccccccccccEEEEEcccEEEccHHHHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHccccccccEEcHcHHHHHHHHccccccccccccccccccccccEEEEcccccccEEEEccccccccccccccccccccccccccccccEEccccccccccccccccccEEccccccccccccccccccccccccccccccccccEEEEcccccccccccccccHHcccccccccccEEEcccccccEEEEccccccccccccccccccccccccccccccEEEccccccEEEEEccccccccccccccccccccccccccEEcccccccccHHHHHHHHEHcccc
mkpikytrpcldcrgsrdhgifqindkywctasgpagkechakcssfednnitddVACVVKIHSQtqrargngfqawstyhycntnskvstYYSSSFNCLVLICFLSCILKSSTLNSlrslgggftgfhsgqmsglaryggvspstILCIKVSTLSRILIYIFKIWCKThmalsrltprylhvdtyskisdpiftdRFRDRIWFLALLINLSSFFVSVPLMLISLEIFKELNGLNFRIKVFSHcrnegrpqsamhfsPIAACLLVLVYCTllprqiegkrfgACELAKFLVRqrgiarrdvptWVCIAtkesnrnsnarspkngngsrdhgifqindkywctasgpagkechakcssfednnitddVACVVKIHSQtqrargngfqawstyhycntnskvstydhaddmgevSACACYMHVNYLGSSLKLETVLMSSEKIFISYSSTHHISKMANKFKFNLfkdhaddmgtCTWEKLALALAKKkthpmfgklahfESQELFLSSalkkpgaaalggcagrpcrnngtctpvsggvvnftctcpsggqgqsgleiTPVYLWLMKLKTLVMVQYYFRrkstsphksrgqgqsgleiTPVYLWLMKMKTLVMVQYYLQQnisplkdgnlsfycnctedftgeycqfensaacvtlnpcqnnatcvaspgdkqitclclkggtvsseycqfensaacvtlnpcqnnatcvaspgdkqitclclkgfegphrelpvesvdeppsedetsvdlqlgsqansyNWAHMLIVTTGS
mkpikytrpcldcrgsrDHGIFQINDKYWCTASGPAGKECHAKCSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTYHYCNTNSKVSTYYSSSFNCLVLICFLSCILKSSTLNSLRSLGGGFTGFHSGQMSGLARYGGVSPSTILCIKVSTLSRILIYIFKIWCKTHMALSRLTPRYLHVDTYSKISDPIFTDRFRDRIWFLALLINLSSFFVSVPLMLISLEIFKELNGLNFRIKVFSHCRNEGRPQSAMHFSPIAACLLVLVYCTLLPRQIEGKRFGACELAKFlvrqrgiarrdvptwvciatkesnrnsnarspkngngsrdHGIFQINDKYWCTASGPAGKECHAKCSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTYHYCNTNSKVSTYDHADDMGEVSACACYMHVNYLGSSLKLETVLMSSEKIFISYSSTHHISKMANKFKFNLFKDHADDMGTCTWEKLALALAKKKTHPMFGKLAHFESQELFLSSALKKPGAAALGGCAGRPCRNNGTCTPVSGGVVNFTCTCPSGGQGQSGLEITPVYLWLMKLKTLVMVQYYFRRKstsphksrgqgqsglEITPVYLWLMKMKTLVMVQYYLQQNISPLKDGNLSFYCNCTEDFTGEYCQFENSAACVTLNPCQNNATCVASPGDKQITCLCLKGGTVSSEYCQFENSAACVTLNPCQNNATCVASPGDKQITCLCLKGFEGPHRELPVESVDEPPSEDETSVDLQLgsqansynwAHMLIVTTGS
MKPIKYTRPCLDCRGSRDHGIFQINDKYWCTASGPAGKECHAKCSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTYHYCNTNSKVSTYYSSSFNCLVLICFLSCILKSSTLNSLRSLGGGFTGFHSGQMSGLARYGGVSPSTILCIKVSTLSRILIYIFKIWCKTHMALSRLTPRYLHVDTYSKISDPIFTDRFRDRIWFLALLINLSSFFVSVPLMLISLEIFKELNGLNFRIKVFSHCRNEGRPQSAMHFSPIAACLLVLVYCTLLPRQIEGKRFGACELAKFLVRQRGIARRDVPTWVCIATKESNRNSNARSPKNGNGSRDHGIFQINDKYWCTASGPAGKECHAKCSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTYHYCNTNSKVSTYDHADDMGEVSACACYMHVNYLGSSLKLETVLMSSEKIFISYSSTHHISKMANKFKFNLFKDHADDMGTCTWEklalalakkkTHPMFGKLAHFESQELFLSSalkkpgaaalggcagrpcrNNGTCTPVSGGVVNFTCTCPSGGQGQSGLEITPVYLWLMKLKTLVMVQYYFRRKSTSPHKSRGQGQSGLEITPVYLWLMKMKTLVMVQYYLQQNISPLKDGNLSFYCNCTEDFTGEYCQFENSAACVTLNPCQNNATCVASPGDKQITCLCLKGGTVSSEYCQFENSAACVTLNPCQNNATCVASPGDKQITCLCLKGFEGPHRELPVESVDEPPSEDETSVDLQLGSQANSYNWAHMLIVTTGS
*****YTRPCLDCRGSRDHGIFQINDKYWCTASGPAGKECHAKCSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTYHYCNTNSKVSTYYSSSFNCLVLICFLSCILKSSTLNSLRSLGGGFTGFHSGQMSGLARYGGVSPSTILCIKVSTLSRILIYIFKIWCKTHMALSRLTPRYLHVDTYSKISDPIFTDRFRDRIWFLALLINLSSFFVSVPLMLISLEIFKELNGLNFRIKVFSHCRNEGRPQSAMHFSPIAACLLVLVYCTLLPRQIEGKRFGACELAKFLVRQRGIARRDVPTWVCIAT*********************GIFQINDKYWCTASGPAGKECHAKCSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTYHYCNTNSKVSTYDHADDMGEVSACACYMHVNYLGSSLKLETVLMSSEKIFISYSSTHHISKMANKFKFNLFKDHADDMGTCTWEKLALALAKKKTHPMFGKLAHFESQELFLSSALKKPGAAALGGCAGRPCRNNGTCTPVSGGVVNFTCTCPSGGQGQSGLEITPVYLWLMKLKTLVMVQYYFR****************LEITPVYLWLMKMKTLVMVQYYLQQNISPLKDGNLSFYCNCTEDFTGEYCQFENSAACVTLNPCQNNATCVASPGDKQITCLCLKGGTVSSEYCQFENSAACVTLNPCQNNATCVASPGDKQITCLCLKGFE*******************************SYNWAHMLIV****
****KYTRPCLDCRGSRDHGIFQINDKYWCTASGPAGKECHAKCSSFEDNNITDDVACVVKIHSQTQ***GNGFQAWSTYHYCNTNSKVSTYYSSSFNCLVLICFLSCILKSSTLNSLRSLGGGFTGFHSGQMSGLARYGGVSPSTILCIKVSTLSRILIYIFKIWCKTHMALSRLTPRYLHVDTYSKISDPIFTDRFRDRIWFLALLINLSSFFVSVPLMLISLEIFKELNGLNFRIKVFSHCRNEGRPQSAMHFSPIAACLLVLVYCTLLPRQIEGKRFGACELAKFLVRQRGIARRDVPTWVCIATK****************SRDHGIFQINDKYWCTASGPAGKECHAKCSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTYHYCNTNSKVSTYDHADDMGEVSACACYMHVNYLGSSLKLETVLMSSEKIFISYSSTHHISKMANKFKFNLFKDHADDMGTCTWEKLALALAKKKTHPMFGKLAHFESQELFLSSALKKPGAAALGGCAGRPCRNNGTCTPVSGGVVNFTCTCPSGGQGQSGLEITPVYLWLMKLKTLVMVQYYFRRKSTSPHKSRGQGQSGLEITPVYLWLMKMKTLVMVQYYLQQNISPLKDGNLSFYCNCTEDFTGEYCQFENSAACVTLNPCQNNATCVASPGDKQITCLCLKGGTVSSEYCQFENSAACVTLNPCQNNATCVASPGDKQITCLCLKGFEGPHRELPVESVDEPPSEDETSVDLQLGSQANSYNWAHMLIVTTG*
MKPIKYTRPCLDCRGSRDHGIFQINDKYWCTASGPAGKECHAKCSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTYHYCNTNSKVSTYYSSSFNCLVLICFLSCILKSSTLNSLRSLGGGFTGFHSGQMSGLARYGGVSPSTILCIKVSTLSRILIYIFKIWCKTHMALSRLTPRYLHVDTYSKISDPIFTDRFRDRIWFLALLINLSSFFVSVPLMLISLEIFKELNGLNFRIKVFSHCRNEGRPQSAMHFSPIAACLLVLVYCTLLPRQIEGKRFGACELAKFLVRQRGIARRDVPTWVCIATKESN*************SRDHGIFQINDKYWCTASGPAGKECHAKCSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTYHYCNTNSKVSTYDHADDMGEVSACACYMHVNYLGSSLKLETVLMSSEKIFISYSSTHHISKMANKFKFNLFKDHADDMGTCTWEKLALALAKKKTHPMFGKLAHFESQELFLSSALKKPGAAALGGCAGRPCRNNGTCTPVSGGVVNFTCTCPSGGQGQSGLEITPVYLWLMKLKTLVMVQYYFRR*************SGLEITPVYLWLMKMKTLVMVQYYLQQNISPLKDGNLSFYCNCTEDFTGEYCQFENSAACVTLNPCQNNATCVASPGDKQITCLCLKGGTVSSEYCQFENSAACVTLNPCQNNATCVASPGDKQITCLCLKGFEGPHRELP****************LQLGSQANSYNWAHMLIVTTGS
*KPIKYTRPCLDCRGSRDHGIFQINDKYWCTASGPAGKECHAKCSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTYHYCNTNSKVSTYYSSSFNCLVLICFLSCILKSSTLNSLRSLGGGFTGFHSGQMSGLARYGGVSPSTILCIKVSTLSRILIYIFKIWCKTHMALSRLTPRYLHVDTYSKISDPIFTDRFRDRIWFLALLINLSSFFVSVPLMLISLEIFKELNGLNFRIKVFSHCRNEGRPQSAMHFSPIAACLLVLVYCTLLPRQIEGKRFGACELAKFLVRQRGIARRDVPTWVCIATKESNRNSNARSPKNGNGSRDHGIFQINDKYWCTASGPAGKECHAKCSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTYHYCNTNSKVSTYDHADDMGEVSACACYMHVNYLGSSLKLETVLMSSEKIFISYSSTHHISKMANKFKFNLFKDHADDMGTCTWEKLALALAKKKTHPMFGKLAHFESQELFLSSALK***AAALGGCAGRPCRNNGTCTPVSGGVVNFTCTCPSGGQGQSGLEITPVYLWLMKLKTLVMVQYYFRRKSTSPHKSRGQGQSGLEITPVYLWLMKMKTLVMVQYYLQQNISPLKDGNLSFYCNCTEDFTGEYCQFENSAACVTLNPCQNNATCVASPGDKQITCLCLKGGTVSSEYCQFENSAACVTLNPCQNNATCVASPGDKQITCLCLKGFEGPHRELPVESVDEPPSEDETSVDLQLGSQANSYNWAHMLIVTTG*
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MKPIKYTRPCLDCRGSRDHGIFQINDKYWCTASGPAGKECHAKCSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTYHYCNTNSKVSTYYSSSFNCLVLICFLSCILKSSTLNSLRSLGGGFTGFHSGQMSGLARYGGVSPSTILCIKVSTLSRILIYIFKIWCKTHMALSRLTPRYLHVDTYSKISDPIFTDRFRDRIWFLALLINLSSFFVSVPLMLISLEIFKELNGLNFRIKVFSHCRNEGRPQSAMHFSPIAACLLVLVYCTLLPRQIEGKRFGACELAKFLVRQRGIARRDVPTWVCIATKESNRNSNARSPKNGNGSRDHGIFQINDKYWCTASGPAGKECHAKCSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTYHYCNTNSKVSTYDHADDMGEVSACACYMHVNYLGSSLKLETVLMSSEKIFISYSSTHHISKMANKFKFNLFKDHADDMGTCTWEKLALALAKKKTHPMFGKLAHFESQELFLSSALKKPGAAALGGCAGRPCRNNGTCTPVSGGVVNFTCTCPSGGQGQSGLEITPVYLWLMKLKTLVMVQYYFRRKSTSPHKSRGQGQSGLEITPVYLWLMKMKTLVMVQYYLQQNISPLKDGNLSFYCNCTEDFTGEYCQFENSAACVTLNPCQNNATCVASPGDKQITCLCLKGGTVSSEYCQFENSAACVTLNPCQNNATCVASPGDKQITCLCLKGFEGPHRELPVESVDEPPSEDETSVDLQLGSQANSYNWAHMLIVTTGS
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query769 2.2.26 [Sep-21-2011]
Q17005140 Lysozyme c-1 OS=Anopheles no N/A 0.157 0.864 0.425 3e-19
Q7YT16141 Lysozyme 1 OS=Musca domes N/A N/A 0.143 0.780 0.420 7e-19
P83972140 Lysozyme D OS=Drosophila no N/A 0.141 0.778 0.393 2e-16
P83971140 Lysozyme A/C OS=Drosophil no N/A 0.141 0.778 0.393 3e-16
P29615141 Lysozyme P OS=Drosophila no N/A 0.163 0.893 0.370 3e-16
P67979148 Lysozyme C OS=Trachypithe N/A N/A 0.175 0.912 0.368 3e-16
P67980148 Lysozyme C OS=Trachypithe N/A N/A 0.175 0.912 0.368 3e-16
Q08694140 Lysozyme B OS=Drosophila no N/A 0.141 0.778 0.393 3e-16
P79811148 Lysozyme C OS=Nasalis lar N/A N/A 0.175 0.912 0.368 3e-16
P79847148 Lysozyme C OS=Pygathrix n N/A N/A 0.175 0.912 0.368 3e-16
>sp|Q17005|LYSC1_ANOGA Lysozyme c-1 OS=Anopheles gambiae GN=AGAP007347 PE=2 SV=2 Back     alignment and function desciption
 Score = 97.4 bits (241), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 57/134 (42%), Positives = 79/134 (58%), Gaps = 13/134 (9%)

Query: 263 LLVLVYCTLLPRQIEGKRFGACELAKFLVRQRGIARRDVPTWVCIATKESNRNSNARSPK 322
           LL +V C  +    E K FG CELAK L    GIA+  +P WVC+   ES  +++A + K
Sbjct: 8   LLAIVACCAVA---EAKTFGKCELAKALANN-GIAKASLPDWVCLVQNESAFSTSA-TNK 62

Query: 323 NGNGSRDHGIFQINDKYWCTASGPAGKECHAKCSSFEDNNITDDVACVVKIHSQTQRARG 382
           N NGS D+GIFQIN+KYWC  SG    +C   C +  +++ITDD+ C   IH +      
Sbjct: 63  NKNGSTDYGIFQINNKYWCD-SGYGSNDCKIACKNLLNDDITDDIKCAKLIHKR------ 115

Query: 383 NGFQAWSTY-HYCN 395
           +GF AW  + ++CN
Sbjct: 116 HGFNAWYGWKNHCN 129




Lysozymes have primarily a bacteriolytic function; those in tissues and body fluids are associated with the monocyte-macrophage system and enhance the activity of immunoagents.
Anopheles gambiae (taxid: 7165)
EC: 3EC: .EC: 2EC: .EC: 1EC: .EC: 1EC: 7
>sp|Q7YT16|LYS1_MUSDO Lysozyme 1 OS=Musca domestica PE=1 SV=1 Back     alignment and function description
>sp|P83972|LYSD_DROME Lysozyme D OS=Drosophila melanogaster GN=LysD PE=2 SV=1 Back     alignment and function description
>sp|P83971|LYSA_DROME Lysozyme A/C OS=Drosophila melanogaster GN=LysA PE=2 SV=1 Back     alignment and function description
>sp|P29615|LYSP_DROME Lysozyme P OS=Drosophila melanogaster GN=LysP PE=2 SV=1 Back     alignment and function description
>sp|P67979|LYSC_TRAOB Lysozyme C OS=Trachypithecus obscurus GN=LYZ PE=2 SV=1 Back     alignment and function description
>sp|P67980|LYSC_TRAFR Lysozyme C OS=Trachypithecus francoisi GN=LYZ PE=2 SV=1 Back     alignment and function description
>sp|Q08694|LYSB_DROME Lysozyme B OS=Drosophila melanogaster GN=LysB PE=2 SV=2 Back     alignment and function description
>sp|P79811|LYSC_NASLA Lysozyme C OS=Nasalis larvatus GN=LYZ PE=3 SV=1 Back     alignment and function description
>sp|P79847|LYSC_PYGNE Lysozyme C OS=Pygathrix nemaeus GN=LYZ PE=3 SV=1 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query769
260447050590 lysozyme precursor [Tribolium castaneum] 0.191 0.249 0.448 9e-26
195127299 1195 GI13315 [Drosophila mojavensis] gi|19391 0.193 0.124 0.417 1e-25
270004918148 hypothetical protein TcasGA2_TC010351 [T 0.171 0.891 0.485 1e-25
195325805 1056 GM24992 [Drosophila sechellia] gi|194118 0.159 0.116 0.456 2e-25
256861417590 lysozyme [Tribolium castaneum] 0.191 0.249 0.441 2e-25
256861419590 lysozyme [Tribolium castaneum] 0.176 0.230 0.479 2e-25
195492651 967 GE20392 [Drosophila yakuba] gi|194180184 0.231 0.184 0.370 7e-25
194749625 1337 GF24155 [Drosophila ananassae] gi|190624 0.153 0.088 0.453 1e-24
195376757 1101 GJ12084 [Drosophila virilis] gi|19415431 0.156 0.108 0.450 1e-24
195588547868 GD13037 [Drosophila simulans] gi|1941960 0.159 0.141 0.448 2e-24
>gi|260447050|ref|NP_001159495.1| lysozyme precursor [Tribolium castaneum] Back     alignment and taxonomy information
 Score =  125 bits (314), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 69/154 (44%), Positives = 92/154 (59%), Gaps = 7/154 (4%)

Query: 252 SAMHFSPIAACLLVLVYCTLLPRQIEGKRFGACELAKFLVRQRGIARRDVPTWVCIATKE 311
           S    +P++  L++L     +  QIE K F  CELAK L  +  I    + TW+CIA  E
Sbjct: 296 SKSKMNPLSKLLVLLFVSLCVSLQIEAKVFKRCELAKELKNKHHIPGNQLATWMCIANYE 355

Query: 312 SNRNSNARSPKNGNGSRDHGIFQINDKYWCTASGPAGKECHAKCSSFEDNNITDDVACVV 371
           S  N+ A + K G    DHG+FQI+  YWC+ S   GK C+AKCS F +N+I DDVACV 
Sbjct: 356 SGFNTAAINKKTG----DHGLFQISQIYWCSNSNKPGKACNAKCSDFRNNDIKDDVACVK 411

Query: 372 KIHSQTQRARGNGFQAWSTY-HYC--NTNSKVST 402
           KI+++ Q+  GNGF AW  Y  YC  N N+ +ST
Sbjct: 412 KIYNEHQKLSGNGFNAWVAYKKYCRGNNNNNLST 445




Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195127299|ref|XP_002008106.1| GI13315 [Drosophila mojavensis] gi|193919715|gb|EDW18582.1| GI13315 [Drosophila mojavensis] Back     alignment and taxonomy information
>gi|270004918|gb|EFA01366.1| hypothetical protein TcasGA2_TC010351 [Tribolium castaneum] Back     alignment and taxonomy information
>gi|195325805|ref|XP_002029621.1| GM24992 [Drosophila sechellia] gi|194118564|gb|EDW40607.1| GM24992 [Drosophila sechellia] Back     alignment and taxonomy information
>gi|256861417|gb|ACV32411.1| lysozyme [Tribolium castaneum] Back     alignment and taxonomy information
>gi|256861419|gb|ACV32412.1| lysozyme [Tribolium castaneum] Back     alignment and taxonomy information
>gi|195492651|ref|XP_002094083.1| GE20392 [Drosophila yakuba] gi|194180184|gb|EDW93795.1| GE20392 [Drosophila yakuba] Back     alignment and taxonomy information
>gi|194749625|ref|XP_001957239.1| GF24155 [Drosophila ananassae] gi|190624521|gb|EDV40045.1| GF24155 [Drosophila ananassae] Back     alignment and taxonomy information
>gi|195376757|ref|XP_002047159.1| GJ12084 [Drosophila virilis] gi|194154317|gb|EDW69501.1| GJ12084 [Drosophila virilis] Back     alignment and taxonomy information
>gi|195588547|ref|XP_002084019.1| GD13037 [Drosophila simulans] gi|194196028|gb|EDX09604.1| GD13037 [Drosophila simulans] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query769
FB|FBgn0035813972 CG8492 [Drosophila melanogaste 0.184 0.146 0.413 2e-41
FB|FBgn0004425140 LysB "Lysozyme B" [Drosophila 0.158 0.871 0.382 1.9e-18
FB|FBgn0004427140 LysD "Lysozyme D" [Drosophila 0.141 0.778 0.393 4e-18
FB|FBgn0004426140 LysC "Lysozyme C" [Drosophila 0.141 0.778 0.393 5.1e-18
FB|FBgn0004430140 LysS "Lysozyme S" [Drosophila 0.159 0.878 0.358 6.6e-18
FB|FBgn0004428140 LysE "Lysozyme E" [Drosophila 0.158 0.871 0.367 1.1e-17
FB|FBgn0004431142 LysX "Lysozyme X" [Drosophila 0.162 0.880 0.352 1.1e-17
FB|FBgn0004429141 LysP "Lysozyme P" [Drosophila 0.162 0.886 0.373 1.4e-17
UNIPROTKB|P81708129 P81708 "Lysozyme C, milk isozy 0.154 0.922 0.379 3.7e-17
UNIPROTKB|G1K265148 LYZ "Uncharacterized protein" 0.172 0.898 0.376 7.8e-17
FB|FBgn0035813 CG8492 [Drosophila melanogaster (taxid:7227)] Back     alignment and assigned GO terms
 Score = 313 (115.2 bits), Expect = 2.0e-41, Sum P(2) = 2.0e-41
 Identities = 60/145 (41%), Positives = 87/145 (60%)

Query:   277 EGKRFGACELAKFLVRQRGIARRDVPTWVCIATKESNRNSNARSPKNGNGSRDHGIFQIN 336
             + K +  CELAK L  +     R++PTWVCIA  ES+ N+ A    N +GS DHG+FQI+
Sbjct:   594 KAKIYNRCELAKELYHRHKFPMREIPTWVCIAEHESSFNTAAVGKLNADGSEDHGLFQIS 653

Query:   337 DKYWCTASGPAGKECHAKCSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTYH-YC- 394
             D YWCT    +GK CH +C    D++I+DDV C+  IH +  R  G+GF AW+ Y+ +C 
Sbjct:   654 DIYWCTHDQTSGKACHIECDRLLDSDISDDVQCIRTIHEEHTRLSGDGFNAWTVYNGHCR 713

Query:   395 NTN-SKVSTYDHADDMGEVSACACY 418
             N N +K+S     +++ E    + Y
Sbjct:   714 NQNLAKLSDCFDGNEISEADKTSHY 738


GO:0003796 "lysozyme activity" evidence=ISS;NAS
GO:0019730 "antimicrobial humoral response" evidence=NAS
FB|FBgn0004425 LysB "Lysozyme B" [Drosophila melanogaster (taxid:7227)] Back     alignment and assigned GO terms
FB|FBgn0004427 LysD "Lysozyme D" [Drosophila melanogaster (taxid:7227)] Back     alignment and assigned GO terms
FB|FBgn0004426 LysC "Lysozyme C" [Drosophila melanogaster (taxid:7227)] Back     alignment and assigned GO terms
FB|FBgn0004430 LysS "Lysozyme S" [Drosophila melanogaster (taxid:7227)] Back     alignment and assigned GO terms
FB|FBgn0004428 LysE "Lysozyme E" [Drosophila melanogaster (taxid:7227)] Back     alignment and assigned GO terms
FB|FBgn0004431 LysX "Lysozyme X" [Drosophila melanogaster (taxid:7227)] Back     alignment and assigned GO terms
FB|FBgn0004429 LysP "Lysozyme P" [Drosophila melanogaster (taxid:7227)] Back     alignment and assigned GO terms
UNIPROTKB|P81708 P81708 "Lysozyme C, milk isozyme" [Canis lupus familiaris (taxid:9615)] Back     alignment and assigned GO terms
UNIPROTKB|G1K265 LYZ "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by EFICAz Software ?

Prediction LevelEC numberConfidence of Prediction
3rd Layer3.2.1LOW CONFIDENCE prediction!
3rd Layer3.2.1.17LOW CONFIDENCE prediction!

Prediction of Functionally Associated Proteins


Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query769
cd00119123 cd00119, LYZ1, C-type lysozyme (1, 4-beta-N-acetyl 2e-35
smart00263127 smart00263, LYZ1, Alpha-lactalbumin / lysozyme C 2e-28
pfam00062125 pfam00062, Lys, C-type lysozyme/alpha-lactalbumin 3e-25
cd00119123 cd00119, LYZ1, C-type lysozyme (1, 4-beta-N-acetyl 7e-22
smart00263127 smart00263, LYZ1, Alpha-lactalbumin / lysozyme C 2e-18
pfam00062125 pfam00062, Lys, C-type lysozyme/alpha-lactalbumin 1e-14
cd0005438 cd00054, EGF_CA, Calcium-binding EGF-like domain, 0.001
cd0005336 cd00053, EGF, Epidermal growth factor domain, foun 0.002
pfam0000832 pfam00008, EGF, EGF-like domain 0.002
>gnl|CDD|238066 cd00119, LYZ1, C-type lysozyme (1, 4-beta-N-acetylmuramidase, LYZ) and alpha-lactalbumin (lactose synthase B protein, LA) Back     alignment and domain information
 Score =  130 bits (328), Expect = 2e-35
 Identities = 51/127 (40%), Positives = 67/127 (52%), Gaps = 9/127 (7%)

Query: 279 KRFGACELAKFLVRQRGIARRDVPTWVCIATKESNRNSNARSPKNGNGSRDHGIFQINDK 338
           K F  CELAK L R        +  WVC+A  ES  N+ A +  N +GS D+G+FQIN K
Sbjct: 1   KIFTRCELAKELKRLGLYPGISLANWVCLAEHESGFNTQAVN-NNNDGSTDYGLFQINSK 59

Query: 339 YWCT-ASGPAGKECHAKCSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTYH-YCNT 396
           YWC     P+G  CH  CS   D++ITDD+ C  KI  + Q     GF AW  +  +C  
Sbjct: 60  YWCNDGKTPSGNICHISCSKLLDDDITDDIKCAKKIVKEHQ-----GFDAWVAWKNHCQ- 113

Query: 397 NSKVSTY 403
              +S +
Sbjct: 114 GRDLSQW 120


They have a close evolutionary relationship and similar tertiary structure, however, functionally they are quite different. Lysozymes have primarily bacteriolytic function; hydrolysis of peptidoglycan of prokaryotic cell walls and transglycosylation. LA is a calcium-binding metalloprotein that is expressed exclusively in the mammary gland during lactation. LA is the regulatory subunit of the enzyme lactose synthase. The association of LA with the catalytic component of lactose synthase, galactosyltransferase, alters the acceptor substrate specificity of this glycosyltransferase, facilitating biosynthesis of lactose. Length = 123

>gnl|CDD|197612 smart00263, LYZ1, Alpha-lactalbumin / lysozyme C Back     alignment and domain information
>gnl|CDD|200968 pfam00062, Lys, C-type lysozyme/alpha-lactalbumin family Back     alignment and domain information
>gnl|CDD|238066 cd00119, LYZ1, C-type lysozyme (1, 4-beta-N-acetylmuramidase, LYZ) and alpha-lactalbumin (lactose synthase B protein, LA) Back     alignment and domain information
>gnl|CDD|197612 smart00263, LYZ1, Alpha-lactalbumin / lysozyme C Back     alignment and domain information
>gnl|CDD|200968 pfam00062, Lys, C-type lysozyme/alpha-lactalbumin family Back     alignment and domain information
>gnl|CDD|238011 cd00054, EGF_CA, Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins Back     alignment and domain information
>gnl|CDD|238010 cd00053, EGF, Epidermal growth factor domain, found in epidermal growth factor (EGF) presents in a large number of proteins, mostly animal; the list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied; the functional significance of EGF-like domains in what appear to be unrelated proteins is not yet clear; a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase); the domain includes six cysteine residues which have been shown to be involved in disulfide bonds; the main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet; Subdomains between the conserved cysteines vary in length; the region between the 5th and 6th cysteine contains two conserved glycines of which at least one is present in most EGF-like domains; a subset of these bind calcium Back     alignment and domain information
>gnl|CDD|215652 pfam00008, EGF, EGF-like domain Back     alignment and domain information

Conserved Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 769
cd00119123 LYZ1 C-type lysozyme (1, 4-beta-N-acetylmuramidase 100.0
PF00062125 Lys: C-type lysozyme/alpha-lactalbumin family; Int 100.0
smart00263127 LYZ1 Alpha-lactalbumin / lysozyme C. 100.0
smart00263127 LYZ1 Alpha-lactalbumin / lysozyme C. 99.94
cd00119123 LYZ1 C-type lysozyme (1, 4-beta-N-acetylmuramidase 99.94
PF00062125 Lys: C-type lysozyme/alpha-lactalbumin family; Int 99.94
KOG1214|consensus 1289 99.65
KOG1219|consensus 4289 99.49
KOG1219|consensus 4289 99.43
KOG1214|consensus 1289 99.3
KOG4289|consensus 2531 99.28
KOG1217|consensus487 99.2
KOG1217|consensus 487 99.03
KOG4289|consensus 2531 98.99
KOG1225|consensus 525 98.77
KOG1225|consensus 525 98.47
KOG1226|consensus 783 98.28
KOG4260|consensus350 98.21
KOG4260|consensus350 98.2
KOG0994|consensus 1758 97.88
PF0000832 EGF: EGF-like domain This is a sub-family of the P 97.56
smart0017939 EGF_CA Calcium-binding EGF-like domain. 97.47
KOG1226|consensus 783 97.38
PF0000832 EGF: EGF-like domain This is a sub-family of the P 97.24
smart0017939 EGF_CA Calcium-binding EGF-like domain. 97.24
KOG0994|consensus 1758 97.11
cd0005438 EGF_CA Calcium-binding EGF-like domain, present in 97.06
PRK15328160 invasion protein IagB; Provisional 97.04
PRK13722169 lytic transglycosylase; Provisional 96.97
PF0764542 EGF_CA: Calcium-binding EGF domain; InterPro: IPR0 96.94
PF0764542 EGF_CA: Calcium-binding EGF domain; InterPro: IPR0 96.87
cd0005438 EGF_CA Calcium-binding EGF-like domain, present in 96.76
PRK13888206 conjugal transfer protein TrbN; Provisional 96.62
PF1294736 EGF_3: EGF domain; InterPro: IPR024731 This entry 96.46
cd0005336 EGF Epidermal growth factor domain, found in epide 96.35
PF06247197 Plasmod_Pvs28: Plasmodium ookinete surface protein 96.15
smart0018135 EGF Epidermal growth factor-like domain. 96.06
PF01464121 SLT: Transglycosylase SLT domain; InterPro: IPR008 95.74
cd0005336 EGF Epidermal growth factor domain, found in epide 95.73
smart0018135 EGF Epidermal growth factor-like domain. 95.43
KOG1836|consensus 1705 95.29
PRK13864245 type IV secretion system lytic transglycosylase Vi 95.08
cd00254113 LT_GEWL Lytic Transglycosylase (LT) and Goose Egg 94.86
PF1266224 cEGF: Complement Clr-like EGF-like 94.85
PF1266224 cEGF: Complement Clr-like EGF-like 94.84
PF06247197 Plasmod_Pvs28: Plasmodium ookinete surface protein 94.2
PF1294736 EGF_3: EGF domain; InterPro: IPR024731 This entry 94.07
PF0797432 EGF_2: EGF-like domain; InterPro: IPR013111 A sequ 93.61
PF0797432 EGF_2: EGF-like domain; InterPro: IPR013111 A sequ 93.39
PF1266113 hEGF: Human growth factor-like EGF; PDB: 2YGQ_A 2E 93.2
PF0673777 Transglycosylas: Transglycosylase-like domain; Int 92.59
PF1266113 hEGF: Human growth factor-like EGF; PDB: 2YGQ_A 2E 91.67
cd01021166 GEWL Goose Egg White Lysozyme domain. Eukaryotic " 90.62
smart0005163 DSL delta serrate ligand. 89.98
KOG1836|consensus 1705 89.65
KOG1218|consensus316 87.26
PRK13888206 conjugal transfer protein TrbN; Provisional 85.88
PHA03099139 epidermal growth factor-like protein (EGF-like pro 85.57
PF1467036 FXa_inhibition: Coagulation Factor Xa inhibitory s 85.38
PHA02887126 EGF-like protein; Provisional 84.28
PF1467036 FXa_inhibition: Coagulation Factor Xa inhibitory s 83.39
smart0005163 DSL delta serrate ligand. 81.39
cd01475224 vWA_Matrilin VWA_Matrilin: In cartilaginous plate, 81.14
PHA03099139 epidermal growth factor-like protein (EGF-like pro 80.79
PRK15470203 emtA lytic murein endotransglycosylase E; Provisio 80.78
KOG3516|consensus 1306 80.57
>cd00119 LYZ1 C-type lysozyme (1, 4-beta-N-acetylmuramidase, LYZ) and alpha-lactalbumin (lactose synthase B protein, LA) Back     alignment and domain information
Probab=100.00  E-value=2.8e-46  Score=347.78  Aligned_cols=119  Identities=42%  Similarity=0.834  Sum_probs=112.5

Q ss_pred             eeecchHHHHHHHHhcCC-CCCCcccceEeeccccCCCcccccCCCCCCCceeeeeeeccccccCCCCC-Cccccccccc
Q psy9686         279 KRFGACELAKFLVRQRGI-ARRDVPTWVCIATKESNRNSNARSPKNGNGSRDHGIFQINDKYWCTASGP-AGKECHAKCS  356 (769)
Q Consensus       279 k~~~rCela~~l~~~~g~-~~~~l~~wvCla~~eS~~~t~a~~~~~~~gs~~yGifQIn~~~WC~~~~~-~~~~C~~~C~  356 (769)
                      |||+|||||++|++ +|| ++.+|++|||||++||+|||+|+++ |.|||+||||||||++|||+++++ ++|.|+|+|+
T Consensus         1 k~~~rCeLa~~L~~-~g~~~~~~l~~Wvcia~~ES~~nt~a~~~-n~~gs~dyGlfQINs~~WC~~~~~~~~n~C~i~C~   78 (123)
T cd00119           1 KIFTRCELAKELKR-LGLYPGISLANWVCLAEHESGFNTQAVNN-NNDGSTDYGLFQINSKYWCNDGKTPSGNICHISCS   78 (123)
T ss_pred             CcCcHhHHHHHHHH-cCCCCCCCHHHHHHHHHHHHCCCccceec-CCCCCeeEeEEEecchhhccCCCCCCCCCcCCCHH
Confidence            79999999999998 576 9999999999999999999999995 679999999999999999999876 5899999999


Q ss_pred             cccCCChhHHHHHHHHHHhcccccccCcccccccCc-cccCCCCCccccc
Q psy9686         357 SFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTYH-YCNTNSKVSTYDH  405 (769)
Q Consensus       357 ~ll~~di~~~i~Cak~i~~~~~~~~~~G~~aW~~w~-~C~g~~~l~~~~~  405 (769)
                      +||+|||+|||+|||+|+++|     +||+||++|+ +|+|+ +|++|..
T Consensus        79 ~Ll~ddI~~~i~CAk~I~~~~-----~G~~aW~~w~~~C~g~-~L~~~~~  122 (123)
T cd00119          79 KLLDDDITDDIKCAKKIVKEH-----QGFDAWVAWKNHCQGR-DLSQWVK  122 (123)
T ss_pred             HhccccHHHHHHHHHHHHhcC-----CCchhHHHHHHhCCCC-CCccccC
Confidence            999999999999999999996     7999999999 99997 9999963



They have a close evolutionary relationship and similar tertiary structure, however, functionally they are quite different. Lysozymes have primarily bacteriolytic function; hydrolysis of peptidoglycan of prokaryotic cell walls and transglycosylation. LA is a calcium-binding metalloprotein that is expressed exclusively in the mammary gland during lactation. LA is the regulatory subunit of the enzyme lactose synthase. The association of LA with the catalytic component of lactose synthase, galactosyltransferase, alters the acceptor substrate specificity of this glycosyltransferase, facilitating biosynthesis of lactose.

>PF00062 Lys: C-type lysozyme/alpha-lactalbumin family; InterPro: IPR001916 O-Glycosyl hydrolases 3 Back     alignment and domain information
>smart00263 LYZ1 Alpha-lactalbumin / lysozyme C Back     alignment and domain information
>smart00263 LYZ1 Alpha-lactalbumin / lysozyme C Back     alignment and domain information
>cd00119 LYZ1 C-type lysozyme (1, 4-beta-N-acetylmuramidase, LYZ) and alpha-lactalbumin (lactose synthase B protein, LA) Back     alignment and domain information
>PF00062 Lys: C-type lysozyme/alpha-lactalbumin family; InterPro: IPR001916 O-Glycosyl hydrolases 3 Back     alignment and domain information
>KOG1214|consensus Back     alignment and domain information
>KOG1219|consensus Back     alignment and domain information
>KOG1219|consensus Back     alignment and domain information
>KOG1214|consensus Back     alignment and domain information
>KOG4289|consensus Back     alignment and domain information
>KOG1217|consensus Back     alignment and domain information
>KOG1217|consensus Back     alignment and domain information
>KOG4289|consensus Back     alignment and domain information
>KOG1225|consensus Back     alignment and domain information
>KOG1225|consensus Back     alignment and domain information
>KOG1226|consensus Back     alignment and domain information
>KOG4260|consensus Back     alignment and domain information
>KOG4260|consensus Back     alignment and domain information
>KOG0994|consensus Back     alignment and domain information
>PF00008 EGF: EGF-like domain This is a sub-family of the Pfam entry This is a sub-family of the Pfam entry; InterPro: IPR006209 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins Back     alignment and domain information
>smart00179 EGF_CA Calcium-binding EGF-like domain Back     alignment and domain information
>KOG1226|consensus Back     alignment and domain information
>PF00008 EGF: EGF-like domain This is a sub-family of the Pfam entry This is a sub-family of the Pfam entry; InterPro: IPR006209 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins Back     alignment and domain information
>smart00179 EGF_CA Calcium-binding EGF-like domain Back     alignment and domain information
>KOG0994|consensus Back     alignment and domain information
>cd00054 EGF_CA Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins Back     alignment and domain information
>PRK15328 invasion protein IagB; Provisional Back     alignment and domain information
>PRK13722 lytic transglycosylase; Provisional Back     alignment and domain information
>PF07645 EGF_CA: Calcium-binding EGF domain; InterPro: IPR001881 A sequence of about forty amino-acid residues found in epidermal growth factor (EGF) has been shown [, , , , , ] to be present in a large number of membrane-bound and extracellular, mostly animal, proteins Back     alignment and domain information
>PF07645 EGF_CA: Calcium-binding EGF domain; InterPro: IPR001881 A sequence of about forty amino-acid residues found in epidermal growth factor (EGF) has been shown [, , , , , ] to be present in a large number of membrane-bound and extracellular, mostly animal, proteins Back     alignment and domain information
>cd00054 EGF_CA Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins Back     alignment and domain information
>PRK13888 conjugal transfer protein TrbN; Provisional Back     alignment and domain information
>PF12947 EGF_3: EGF domain; InterPro: IPR024731 This entry represents an EGF domain found in the the C terminus of malarial parasite merozoite surface protein 1 [], as well as other proteins Back     alignment and domain information
>cd00053 EGF Epidermal growth factor domain, found in epidermal growth factor (EGF) presents in a large number of proteins, mostly animal; the list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied; the functional significance of EGF-like domains in what appear to be unrelated proteins is not yet clear; a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase); the domain includes six cysteine residues which have been shown to be involved in disulfide bonds; the main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet; Subdomains between the conserved cysteines vary in length; the region between the 5th and 6th cysteine contains two conserved glycines of which at least one is present in most EGF-like domains; a subset of these bind calcium Back     alignment and domain information
>PF06247 Plasmod_Pvs28: Plasmodium ookinete surface protein Pvs28; InterPro: IPR010423 This family consists of several ookinete surface protein (Pvs28) from several species of Plasmodium Back     alignment and domain information
>smart00181 EGF Epidermal growth factor-like domain Back     alignment and domain information
>PF01464 SLT: Transglycosylase SLT domain; InterPro: IPR008258 Bacterial lytic transglycosylases degrade murein via cleavage of the beta-1,4-glycosidic bond between N-acetylmuramic acid and N-acetylglucosamine, with the concomitant formation of a 1,6-anhydrobond in the muramic acid residue Back     alignment and domain information
>cd00053 EGF Epidermal growth factor domain, found in epidermal growth factor (EGF) presents in a large number of proteins, mostly animal; the list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied; the functional significance of EGF-like domains in what appear to be unrelated proteins is not yet clear; a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase); the domain includes six cysteine residues which have been shown to be involved in disulfide bonds; the main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet; Subdomains between the conserved cysteines vary in length; the region between the 5th and 6th cysteine contains two conserved glycines of which at least one is present in most EGF-like domains; a subset of these bind calcium Back     alignment and domain information
>smart00181 EGF Epidermal growth factor-like domain Back     alignment and domain information
>KOG1836|consensus Back     alignment and domain information
>PRK13864 type IV secretion system lytic transglycosylase VirB1; Provisional Back     alignment and domain information
>cd00254 LT_GEWL Lytic Transglycosylase (LT) and Goose Egg White Lysozyme (GEWL) domain Back     alignment and domain information
>PF12662 cEGF: Complement Clr-like EGF-like Back     alignment and domain information
>PF12662 cEGF: Complement Clr-like EGF-like Back     alignment and domain information
>PF06247 Plasmod_Pvs28: Plasmodium ookinete surface protein Pvs28; InterPro: IPR010423 This family consists of several ookinete surface protein (Pvs28) from several species of Plasmodium Back     alignment and domain information
>PF12947 EGF_3: EGF domain; InterPro: IPR024731 This entry represents an EGF domain found in the the C terminus of malarial parasite merozoite surface protein 1 [], as well as other proteins Back     alignment and domain information
>PF07974 EGF_2: EGF-like domain; InterPro: IPR013111 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins Back     alignment and domain information
>PF07974 EGF_2: EGF-like domain; InterPro: IPR013111 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins Back     alignment and domain information
>PF12661 hEGF: Human growth factor-like EGF; PDB: 2YGQ_A 2E26_A 3A7Q_A 2YGP_A 2YGO_A 1HRE_A 1HAE_A 1HAF_A 1HRF_A Back     alignment and domain information
>PF06737 Transglycosylas: Transglycosylase-like domain; InterPro: IPR010618 This family of proteins is very likely to act as transglycosylase enzymes related to IPR001916 from INTERPRO and IPR008258 from INTERPRO Back     alignment and domain information
>PF12661 hEGF: Human growth factor-like EGF; PDB: 2YGQ_A 2E26_A 3A7Q_A 2YGP_A 2YGO_A 1HRE_A 1HAE_A 1HAF_A 1HRF_A Back     alignment and domain information
>cd01021 GEWL Goose Egg White Lysozyme domain Back     alignment and domain information
>smart00051 DSL delta serrate ligand Back     alignment and domain information
>KOG1836|consensus Back     alignment and domain information
>KOG1218|consensus Back     alignment and domain information
>PRK13888 conjugal transfer protein TrbN; Provisional Back     alignment and domain information
>PHA03099 epidermal growth factor-like protein (EGF-like protein); Provisional Back     alignment and domain information
>PF14670 FXa_inhibition: Coagulation Factor Xa inhibitory site; PDB: 3Q3K_B 1NFY_B 1LQD_A 1G2L_B 1IQF_L 2UWP_B 2VH6_B 3KQC_L 2P93_L 2BQW_A Back     alignment and domain information
>PHA02887 EGF-like protein; Provisional Back     alignment and domain information
>PF14670 FXa_inhibition: Coagulation Factor Xa inhibitory site; PDB: 3Q3K_B 1NFY_B 1LQD_A 1G2L_B 1IQF_L 2UWP_B 2VH6_B 3KQC_L 2P93_L 2BQW_A Back     alignment and domain information
>smart00051 DSL delta serrate ligand Back     alignment and domain information
>cd01475 vWA_Matrilin VWA_Matrilin: In cartilaginous plate, extracellular matrix molecules mediate cell-matrix and matrix-matrix interactions thereby providing tissue integrity Back     alignment and domain information
>PHA03099 epidermal growth factor-like protein (EGF-like protein); Provisional Back     alignment and domain information
>PRK15470 emtA lytic murein endotransglycosylase E; Provisional Back     alignment and domain information
>KOG3516|consensus Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query769
2fbd_A122 The Crystallographic Structure Of The Digestive Lys 4e-19
3cb7_A126 The Crystallographic Structure Of The Digestive Lys 7e-17
1iiz_A120 Crystal Structure Of The Induced Antibacterial Prot 1e-16
1qqy_A130 X-Ray Crystal Structure Analysis Of Canine Milk Lys 3e-16
1el1_A130 X-Ray Crystal Structure Analysis Of Canine Milk Lys 3e-16
2cwi_A129 X-Ray Crystal Structure Analysis Of Recombinant Wil 4e-16
2lhm_A130 Crystal Structures Of The Apo-And Holomutant Human 1e-15
1i22_A130 Mutant Human Lysozyme (A83kQ86DA92D) Length = 130 2e-15
2rsc_A120 Solution Structure Of The Bombyx Mori Lysozyme Leng 2e-15
3b6l_A147 Crystal Structure Of Lysozyme Folded In Sds And 2-M 4e-15
1i20_A130 Mutant Human Lysozyme (A92d) Length = 130 7e-15
1gfg_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 7e-15
1di3_A130 Role Of Amino Acid Residues At Turns In The Conform 7e-15
2z2e_A129 Crystal Structure Of Canine Milk Lysozyme Stabilize 7e-15
1gd6_A119 Structure Of The Bombyx Mori Lysozyme Length = 119 8e-15
1i1z_A130 Mutant Human Lysozyme (Q86d) Length = 130 9e-15
1c7p_A134 Crystal Structure Of Mutant Human Lysozyme With Fou 9e-15
1c46_A131 Mutant Human Lysozyme With Foreign N-Terminal Resid 1e-14
1gb5_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 1e-14
2eql_A129 Crystallographic Studies Of A Calcium Binding Lysoz 1e-14
1lhi_A130 Role Of Proline Residues In Human Lysozyme Stabilit 2e-14
1b5u_A130 Contribution Of Hydrogen Bonds To The Conformationa 2e-14
1lsy_A147 Crystal Structure Of The Mutant D52s Hen Egg White 2e-14
1ouc_A130 Contribution Of Hydrophobic Residues To The Stabili 3e-14
1cj7_A130 T11v Mutant Human Lysozyme Length = 130 3e-14
1gdx_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 3e-14
1gfv_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 3e-14
1d6q_A130 Human Lysozyme E102 Mutant Labelled With 2',3'-Epox 3e-14
1gfe_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 4e-14
1gfj_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 4e-14
1oub_A130 Contribution Of Hydrophobic Residues To The Stabili 4e-14
1bb3_A130 Human Lysozyme Mutant A96l Length = 130 4e-14
1lhj_A130 Role Of Proline Residues In Human Lysozyme Stabilit 4e-14
1gf8_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 4e-14
1gfu_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 4e-14
1gf3_A130 Buried Polar Mutant Human Lysozyme Length = 130 4e-14
1ip3_A130 G68a Human Lysozyme Length = 130 4e-14
1gbo_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 4e-14
1gf7_A130 Buried Polar Mutant Human Lysozyme Length = 130 4e-14
1ip6_A130 G127a Human Lysozyme Length = 130 4e-14
1gb2_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 4e-14
1oug_A130 Contribution Of Hydrophobic Residues To The Stabili 5e-14
1b7m_A130 Verification Of Spmp Using Mutant Human Lysozymes L 5e-14
1ioc_A134 Crystal Structure Of Mutant Human Lysozyme, Eaea-I5 5e-14
1gfa_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 5e-14
1cj6_A130 T11a Mutant Human Lysozyme Length = 130 5e-14
1inu_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 5e-14
3ln2_A130 Crystal Structure Of A Charge Engineered Human Lyso 5e-14
1lhh_A130 Role Of Proline Residues In Human Lysozyme Stabilit 5e-14
1cj8_A130 T40a Mutant Human Lysozyme Length = 130 5e-14
1ckf_A130 T52a Mutant Human Lysozyme Length = 130 5e-14
2hea_A130 Contribution Of Water Molecules In The Interior Of 5e-14
1ckc_A130 T43a Mutant Human Lysozyme Length = 130 5e-14
1gf9_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 5e-14
1b5x_A130 Contribution Of Hydrogen Bonds To The Conformationa 5e-14
1b7o_A130 Verification Of Spmp Using Mutant Human Lysozymes L 5e-14
1ouh_A130 Contribution Of Hydrophobic Residues To The Stabili 5e-14
1eqe_A130 Crystal Structures Of Salt Bridge Mutants Of Human 5e-14
1gb0_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 6e-14
1ge0_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 6e-14
1gfr_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 6e-14
1gb6_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 6e-14
1gay_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 6e-14
133l_A130 Role Of Arg 115 In The Catalytic Action Of Human Ly 6e-14
1eq5_A130 Crystal Structures Of Salt Bridge Mutants Of Human 6e-14
1gby_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 6e-14
1b7q_A130 Verification Of Spmp Using Mutant Human Lysozymes L 6e-14
1gb7_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 6e-14
1gb9_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 6e-14
1lzs_A130 Structural Changes Of The Active Site Cleft And Dif 6e-14
1ouf_A130 Contribution Of Hydrophobic Residues To The Stabili 6e-14
1oue_A130 Contribution Of Hydrophobic Residues To The Stabili 6e-14
1gb8_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 6e-14
1gfk_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 6e-14
1lyy_A130 Amyloidogenic Variant (Asp67his) Of Human Lysozyme 6e-14
1ip7_A130 G129a Human Lysozyme Length = 130 6e-14
1ckh_A130 T70v Mutant Human Lysozyme Length = 130 6e-14
1ckg_A130 T52v Mutant Human Lysozyme Length = 130 6e-14
134l_A130 Role Of Arg 115 In The Catalytic Action Of Human Ly 6e-14
1ckd_A130 T43v Mutant Human Lysozyme Length = 130 6e-14
1gfh_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 6e-14
1b7s_A130 Verification Of Spmp Using Mutant Human Lysozymes L 6e-14
1wqp_A130 Contribution Of Hydrogen Bonds To The Conformationa 6e-14
1gft_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 6e-14
1gb3_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 7e-14
1wqn_A130 Contribution Of Hydrogen Bonds To The Conformationa 7e-14
1gaz_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 7e-14
1lhl_A130 Role Of Proline Residues In Human Lysozyme Stabilit 7e-14
1b5w_A130 Contribution Of Hydrogen Bonds To The Conformationa 7e-14
1gbw_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 7e-14
1wqo_A130 Contribution Of Hydrogen Bonds To The Conformationa 7e-14
1gbz_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 7e-14
1yam_A130 Contribution Of Hydrophobic Residues To The Stabili 7e-14
1gbx_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 8e-14
1w08_A130 Structure Of T70n Human Lysozyme Length = 130 8e-14
1ip4_A130 G72a Human Lysozyme Length = 130 8e-14
1ip1_A130 G37a Human Lysozyme Length = 130 8e-14
2heb_A130 Contribution Of Water Molecules In The Interior Of 9e-14
1gdw_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 9e-14
1yao_A130 Contribution Of Hydrophobic Residues To The Stabili 9e-14
1yap_A130 Contribution Of Hydrophobic Residues To The Stabili 9e-14
1yan_A130 Contribution Of Hydrophobic Residues To The Stabili 9e-14
1yaq_A130 Contribution Of Hydrophobic Residues To The Stabili 9e-14
1gf5_A130 Buried Polar Mutant Human Lysozyme Length = 130 9e-14
1b5y_A130 Contribution Of Hydrogen Bonds To The Conformationa 1e-13
1b5v_A130 Contribution Of Hydrogen Bonds To The Conformationa 1e-13
1c43_A130 Mutant Human Lysozyme With Foreign N-Terminal Resid 1e-13
1b5z_A130 Contribution Of Hydrogen Bonds To The Conformationa 1e-13
1cj9_A130 T40v Mutant Human Lysozyme Length = 130 1e-13
1c45_A130 Mutant Human Lysozyme With Foreign N-Terminal Resid 1e-13
1jkc_A130 Human Lysozyme Mutant With Trp 109 Replaced By Phe 1e-13
1wqq_A130 Contribution Of Hydrogen Bonds To The Conformationa 1e-13
2mee_A130 Contribution Of Hydrophobic Effect To The Conformat 1e-13
2meb_A130 Changes In Conformational Stability Of A Series Of 1e-13
2mef_A130 Contribution Of Hydrophobic Effect To The Conformat 1e-13
2mec_A130 Changes In Conformational Stability Of A Series Of 1e-13
1gf0_A130 Buried Polar Mutant Human Lysozyme Length = 130 1e-13
1gez_A130 Buried Polar Mutant Human Lysozyme Length = 130 1e-13
1lz5_A134 Structural And Functional Analyses Of The Arg-Gly-A 1e-13
1eq4_A130 Crystal Structures Of Salt Bridge Mutants Of Human 1e-13
1ge3_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 1e-13
1ge4_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 1e-13
1jka_A130 Human Lysozyme Mutant With Glu 35 Replaced By Asp L 1e-13
1tcy_A130 Dissection Of The Functional Role Of Structural Ele 1e-13
1wqm_A130 Contribution Of Hydrogen Bonds To The Conformationa 1e-13
1gf6_A130 Buried Polar Mutant Human Lysozyme Length = 130 2e-13
1ip5_A130 G105a Human Lysozyme Length = 130 2e-13
1ouj_A130 Contribution Of Hydrophobic Residues To The Stabili 2e-13
1oui_A130 Contribution Of Hydrophobic Residues To The Stabili 2e-13
1oud_A130 Contribution Of Hydrophobic Residues To The Stabili 2e-13
1gf4_A130 Buried Polar Mutant Human Lysozyme Length = 130 2e-13
2mea_A130 Changes In Conformational Stability Of A Series Of 2e-13
2med_A130 Contribution Of Hydrophobic Effect To The Conformat 2e-13
1tdy_A130 Dissection Of The Functional Role Of Structural Ele 2e-13
1laa_A130 X-Ray Structure Of Glu 53 Human Lysozyme Length = 1 2e-13
1di5_A129 Role Of Amino Acid Residues At Turns In The Conform 2e-13
1b7l_A130 Verification Of Spmp Using Mutant Human Lysozymes L 2e-13
2meh_A130 Contribution Of Hydrophobic Effect To The Conformat 2e-13
1loz_A130 Amyloidogenic Variant (I56t) Variant Of Human Lysoz 2e-13
1gev_A130 Buried Polar Mutant Human Lysozyme Length = 130 3e-13
2hec_A130 Contribution Of Water Molecules In The Interior Of 3e-13
2hef_A130 Contribution Of Water Molecules In The Interior Of 3e-13
2hed_A130 Contribution Of Water Molecules In The Interior Of 3e-13
1ip2_A130 G48a Human Lysozyme Length = 130 3e-13
2mei_A130 Contribution Of Hydrophobic Effect To The Conformat 3e-13
1jkb_A130 Human Lysozyme Mutant With Glu 35 Replaced By Ala L 3e-13
1ge1_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 3e-13
1bb4_A130 Human Lysozyme Double Mutant A96l, W109h Length = 1 3e-13
1d6p_A130 Human Lysozyme L63 Mutant Labelled With 2',3'-Epoxy 4e-13
1b7r_A130 Verification Of Spmp Using Mutant Human Lysozymes L 4e-13
2meg_A130 Changes In Conformational Stability Of A Series Of 4e-13
1lz6_A138 Structural And Functional Analyses Of The Arg-Gly-A 4e-13
1lmt_A136 Structure Of A Conformationally Constrained Arg-Gly 4e-13
208l_A130 Mutant Human Lysozyme C77a Length = 130 4e-13
1lhk_A130 Role Of Proline Residues In Human Lysozyme Stabilit 5e-13
1b7n_A130 Verification Of Spmp Using Mutant Human Lysozymes L 5e-13
1jkd_A130 Human Lysozyme Mutant With Trp 109 Replaced By Ala 5e-13
2hee_A130 Contribution Of Water Molecules In The Interior Of 5e-13
1tay_A130 Dissection Of The Functional Role Of Structural Ele 5e-13
1ge2_A130 Crystal Structure Of Mutant Human Lysozyme Substitu 6e-13
1b7p_A130 Verification Of Spmp Using Mutant Human Lysozymes L 7e-13
2bqh_A130 Contribution Of Hydrophobic Effect To The Conformat 1e-12
1ghl_A130 The Three-Dimensional Structure Of Pheasant And Gui 2e-12
2bql_A130 Contribution Of Hydrophobic Effect To The Conformat 2e-12
1di4_A128 Role Of Amino Acid Residues At Turns In The Conform 3e-12
2bqm_A130 Contribution Of Hydrophobic Effect To The Conformat 3e-12
1lhm_A130 The Crystal Structure Of A Mutant Lysozyme C77(Slas 3e-12
2bqk_A130 Contribution Of Hydrophobic Effect To The Conformat 3e-12
2bqj_A130 Contribution Of Hydrophobic Effect To The Conformat 3e-12
1ior_A129 Stabilization Of Hen Egg White Lysozyme By A Cavity 3e-12
2bqb_A130 Contribution Of Hydrophobic Effect To The Conformat 4e-12
2bqd_A130 Contribution Of Hydrophobic Effect To The Conformat 5e-12
2bqe_A130 Contribution Of Hydrophobic Effect To The Conformat 5e-12
2bqc_A130 Contribution Of Hydrophobic Effect To The Conformat 5e-12
1lzd_A129 Dissection Of Protein-Carbohydrate Interactions In 7e-12
2bqi_A130 Contribution Of Hydrophobic Effect To The Conformat 1e-11
1her_A129 Structural And Thermodynamic Analysis Of Compensati 1e-11
1ioq_A129 Stabilization Of Hen Egg White Lysozyme By A Cavity 1e-11
1nby_C129 Crystal Structure Of Hyhel-63 Complexed With Hel Mu 1e-11
1iot_A129 Stabilization Of Hen Egg White Lysozyme By A Cavity 1e-11
1qsw_A130 Crystal Structure Analysis Of A Human Lysozyme Muta 1e-11
1heq_A129 Structural And Thermodynamic Analysis Of Compensati 1e-11
1ix0_A130 I59a-3ss Human Lysozyme Length = 130 1e-11
1flu_A129 Hen Egg White Lysozyme Mutant With Alanine Substitu 2e-11
132l_A129 Structural Consequences Of Reductive Methylation Of 2e-11
1a2y_C129 Hen Egg White Lysozyme, D18a Mutant, In Complex Wit 2e-11
1flw_A129 Hen Egg White Lysozyme Mutant With Alanine Substitu 2e-11
1bql_Y129 Structure Of An Anti-Hel Fab Fragment Complexed Wit 2e-11
1ir7_A129 Im Mutant Of Lysozyme Length = 129 2e-11
2iff_Y129 Structure Of An Antibody-Lysozyme Complex: Effect O 2e-11
1kxx_A129 Analysis Of The Stabilization Of Hen Lysozyme With 2e-11
1kxw_A129 Analysis Of The Stabilization Of Hen Lysozyme With 2e-11
1uia_A127 Analysis Of The Stabilization Of Hen Lysozyme With 2e-11
1hep_A129 Structural And Thermodynamic Analysis Of Compensati 2e-11
1lzg_A129 Dissection Of Protein-Carbohydrate Interactions In 2e-11
1jhl_A129 Three-Dimensional Structure Of A Heteroclitic Antig 2e-11
1flq_A129 Hen Egg White Lysozyme Mutant With Alanine Substitu 2e-11
1fbi_X129 Crystal Structure Of A Cross-Reaction Complex Betwe 2e-11
1fdl_Y129 Crystallographic Refinement Of The Three-Dimensiona 2e-11
1uic_A129 Analysis Of The Stabilization Of Hen Lysozyme With 2e-11
1kxy_A129 Analysis Of The Stabilization Of Hen Lysozyme With 2e-11
1hem_A129 Structural And Thermodynamic Analysis Of Compensati 3e-11
1at6_A129 Hen Egg White Lysozyme With A Isoaspartate Residue 3e-11
1v7s_A129 Triclinic Hen Lysozyme Crystallized At 313k From A 3e-11
1uid_A129 Analysis Of The Stabilization Of Hen Lysozyme With 3e-11
1lsg_A144 Three-Dimensional Structure Of The Platelet Integri 3e-11
1lsn_A129 Thermal Stability Determinants Of Chicken Egg-White 3e-11
1uif_A129 Analysis Of The Stabilization Of Hen Lysozyme With 3e-11
1uie_A129 Analysis Of The Stabilization Of Hen Lysozyme With 3e-11
3qy4_A129 Crystallization And In Situ Data Collection Of Lyso 3e-11
1heo_A129 Structural And Thermodynamic Analysis Of Compensati 3e-11
1ivm_A130 Solution Structure Of Mouse Lysozyme M Length = 130 3e-11
1io5_A129 Hydrogen And Hydration Of Hen Egg-White Lysozyme De 4e-11
1hen_A129 Structural And Thermodynamic Analysis Of Compensati 4e-11
1ios_A129 Stabilization Of Hen Egg White Lysozyme By A Cavity 4e-11
1ir9_A129 Im Mutant Of Lysozyme Length = 129 5e-11
1ir8_A129 Im Mutant Of Lysozyme Length = 129 5e-11
1lsm_A129 Thermal Stability Determinants Of Chicken Egg-White 5e-11
1ndg_C129 Crystal Structure Of Fab Fragment Of Antibody Hyhel 5e-11
1h6m_A129 Covalent Glycosyl-Enzyme Intermediate Of Hen Egg Wh 6e-11
1dzb_X129 Crystal Structure Of Phage Library-Derived Single-C 7e-11
1hhl_A129 The Three-Dimensional Structure Of Pheasant And Gui 7e-11
3a3q_A129 Structure Of N59d Hen Egg-White Lysozyme In Complex 7e-11
3ojp_A129 D52n Mutant Of Hen Egg White Lysozyme (Hewl) Length 9e-11
1fly_A129 Hen Egg White Lysozyme Mutant With Alanine Substitu 1e-10
1nbz_C129 Crystal Structure Of Hyhel-63 Complexed With Hel Mu 1e-10
1lz2_A129 Crystallographic Study Of Turkey Egg-White Lysozyme 1e-10
1fn5_A129 Hen Egg White Lysozyme Mutant With Alanine Substitu 1e-10
3ok0_A129 E35a Mutant Of Hen Egg White Lysozyme (Hewl) Length 1e-10
1at5_A129 Hen Egg White Lysozyme With A Succinimide Residue L 1e-10
1bb6_A129 Lysozyme Complex With 4-Methyl-Umbelliferyl Chitotr 1e-10
2z2f_A129 X-Ray Crystal Structure Of Bovine Stomach Lysozyme 5e-10
2bqn_A130 Contribution Of Hydrophobic Effect To The Conformat 8e-10
2ihl_A129 Lysozyme (e.c.3.2.1.17) (japanese Quail) Length = 1 1e-09
2gv0_A131 The Structure Of The Orthorhombic Form Of Soft-Shel 1e-09
2bqo_A130 Contribution Of Hydrophobic Effect To The Conformat 3e-09
2bqg_A130 Contribution Of Hydrophobic Effect To The Conformat 3e-09
1hml_A142 Alpha_lactalbumin Possesses A Distinct Zinc Binding 1e-08
2bqf_A130 Contribution Of Hydrophobic Effect To The Conformat 1e-08
1hfz_A124 Alpha-Lactalbumin Length = 124 1e-08
1f6r_A123 Crystal Structure Of Apo-Bovine Alpha-Lactalbumin L 2e-08
1fkv_A124 Recombinant Goat Alpha-Lactalbumin T29i Length = 12 2e-08
1fkq_A124 Recombinant Goat Alpha-Lactalbumin T29v Length = 12 3e-08
2goi_A138 Crystal Structure Of Mouse Sperm C-Type Lysozyme-Li 4e-08
1a4v_A123 Alpha-Lactalbumin Length = 123 5e-08
3b0i_A124 Crystal Structure Of Recombinant Human Alpha Lactal 5e-08
1hmk_A124 Recombinant Goat Alpha-Lactalbumin Length = 124 9e-08
1hfy_A123 Alpha-Lactalbumin Length = 123 1e-07
3b0k_A123 Crystal Structure Of Alpha-Lactalbumin Length = 123 1e-07
1alc_A123 Refined Structure Of Baboon Alpha-Lactalbumin At 1. 1e-07
1b9o_A123 Human Alpha-Lactalbumin, Low Temperature Form Lengt 1e-07
3b0o_A123 Crystal Structure Of Alpha-Lactalbumin Length = 123 2e-07
1jug_A125 Lysozyme From Echidna Milk (Tachyglossus Aculeatus) 9e-07
3zvq_A70 Crystal Structure Of Proteolyzed Lysozyme Length = 3e-06
2vj3_A135 Human Notch-1 Egfs 11-13 Length = 135 1e-04
1toz_A116 Nmr Structure Of The Human Notch-1 Ligand Binding R 5e-04
>pdb|2FBD|A Chain A, The Crystallographic Structure Of The Digestive Lysozyme 1 From Musca Domestica At 1.90 Ang. Length = 122 Back     alignment and structure

Iteration: 1

Score = 93.6 bits (231), Expect = 4e-19, Method: Compositional matrix adjust. Identities = 49/118 (41%), Positives = 66/118 (55%), Gaps = 9/118 (7%) Query: 279 KRFGACELAKFLVRQRGIARRDVPTWVCIATKESNRNSNARSPKNGNGSRDHGIFQINDK 338 K F C LA+ + G+ + ++P W CIA ES+ +N P N NGS D+GIFQIN+ Sbjct: 1 KTFTRCSLAREMY-ALGVPKSELPQWTCIAEHESSYRTNVVGPTNSNGSNDYGIFQINNY 59 Query: 339 YWCTASGP--AGKECHAKCSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTYHYC 394 YWC S + ECH C + +NI++ V C KI SQ G+ AWST+ YC Sbjct: 60 YWCQPSNGRFSYNECHLSCDALLTDNISNSVTCARKIKSQ------QGWTAWSTWKYC 111
>pdb|3CB7|A Chain A, The Crystallographic Structure Of The Digestive Lysozyme 2 From Musca Domestica At 1.9 Ang. Length = 126 Back     alignment and structure
>pdb|1IIZ|A Chain A, Crystal Structure Of The Induced Antibacterial Protein From Tasar Silkworm, Antheraea Mylitta Length = 120 Back     alignment and structure
>pdb|1QQY|A Chain A, X-Ray Crystal Structure Analysis Of Canine Milk Lysozyme (Apo-Type) Length = 130 Back     alignment and structure
>pdb|1EL1|A Chain A, X-Ray Crystal Structure Analysis Of Canine Milk Lysozyme (Holo-Type) Length = 130 Back     alignment and structure
>pdb|2CWI|A Chain A, X-Ray Crystal Structure Analysis Of Recombinant Wild-Type Canine Milk Lysozyme (Apo-Type) Length = 129 Back     alignment and structure
>pdb|2LHM|A Chain A, Crystal Structures Of The Apo-And Holomutant Human Lysozymes With An Introduced Ca2+ Binding Site Length = 130 Back     alignment and structure
>pdb|1I22|A Chain A, Mutant Human Lysozyme (A83kQ86DA92D) Length = 130 Back     alignment and structure
>pdb|2RSC|A Chain A, Solution Structure Of The Bombyx Mori Lysozyme Length = 120 Back     alignment and structure
>pdb|3B6L|A Chain A, Crystal Structure Of Lysozyme Folded In Sds And 2-Methyl-2, 4-Pentanediol Length = 147 Back     alignment and structure
>pdb|1I20|A Chain A, Mutant Human Lysozyme (A92d) Length = 130 Back     alignment and structure
>pdb|1GFG|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|1DI3|A Chain A, Role Of Amino Acid Residues At Turns In The Conformational Stability And Folding Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|2Z2E|A Chain A, Crystal Structure Of Canine Milk Lysozyme Stabilized Against Non-Enzymatic Deamidation Length = 129 Back     alignment and structure
>pdb|1GD6|A Chain A, Structure Of The Bombyx Mori Lysozyme Length = 119 Back     alignment and structure
>pdb|1I1Z|A Chain A, Mutant Human Lysozyme (Q86d) Length = 130 Back     alignment and structure
>pdb|1C7P|A Chain A, Crystal Structure Of Mutant Human Lysozyme With Four Extra Residues (Eaea) At The N-Terminal Length = 134 Back     alignment and structure
>pdb|1C46|A Chain A, Mutant Human Lysozyme With Foreign N-Terminal Residues Length = 131 Back     alignment and structure
>pdb|1GB5|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|2EQL|A Chain A, Crystallographic Studies Of A Calcium Binding Lysozyme From Equine Milk At 2.5 Angstroms Resolution Length = 129 Back     alignment and structure
>pdb|1LHI|A Chain A, Role Of Proline Residues In Human Lysozyme Stability: A Scanning Calorimetric Study Combined With X-Ray Structure Analysis Of Proline Mutants Length = 130 Back     alignment and structure
>pdb|1B5U|A Chain A, Contribution Of Hydrogen Bonds To The Conformational Stability Of Human Lysozyme: Calorimetry And X-Ray Analysis Of Six Ser->ala Mutant Length = 130 Back     alignment and structure
>pdb|1LSY|A Chain A, Crystal Structure Of The Mutant D52s Hen Egg White Lysozyme With An Oligosaccharide Product Length = 147 Back     alignment and structure
>pdb|1OUC|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: X-Ray Structure Of The V110a Mutant Length = 130 Back     alignment and structure
>pdb|1CJ7|A Chain A, T11v Mutant Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1GDX|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At Left-Handed Helical Positions Length = 130 Back     alignment and structure
>pdb|1GFV|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|1D6Q|A Chain A, Human Lysozyme E102 Mutant Labelled With 2',3'-Epoxypropyl Glycoside Of N-Acetyllactosamine Length = 130 Back     alignment and structure
>pdb|1GFE|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|1GFJ|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|1OUB|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: X-ray Structure Of The V100a Mutant Length = 130 Back     alignment and structure
>pdb|1BB3|A Chain A, Human Lysozyme Mutant A96l Length = 130 Back     alignment and structure
>pdb|1LHJ|A Chain A, Role Of Proline Residues In Human Lysozyme Stability: A Scanning Calorimetric Study Combined With X-Ray Structure Analysis Of Proline Mutants Length = 130 Back     alignment and structure
>pdb|1GF8|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|1GFU|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|1GF3|A Chain A, Buried Polar Mutant Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1IP3|A Chain A, G68a Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1GBO|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|1GF7|A Chain A, Buried Polar Mutant Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1IP6|A Chain A, G127a Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1GB2|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|1OUG|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: X-Ray Structure Of The V2a Mutant Length = 130 Back     alignment and structure
>pdb|1B7M|A Chain A, Verification Of Spmp Using Mutant Human Lysozymes Length = 130 Back     alignment and structure
>pdb|1IOC|A Chain A, Crystal Structure Of Mutant Human Lysozyme, Eaea-I56t Length = 134 Back     alignment and structure
>pdb|1GFA|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|1CJ6|A Chain A, T11a Mutant Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1INU|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|3LN2|A Chain A, Crystal Structure Of A Charge Engineered Human Lysozyme Variant Length = 130 Back     alignment and structure
>pdb|1LHH|A Chain A, Role Of Proline Residues In Human Lysozyme Stability: A Scanning Calorimetric Study Combined With X-Ray Structure Analysis Of Proline Mutants Length = 130 Back     alignment and structure
>pdb|1CJ8|A Chain A, T40a Mutant Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1CKF|A Chain A, T52a Mutant Human Lysozyme Length = 130 Back     alignment and structure
>pdb|2HEA|A Chain A, Contribution Of Water Molecules In The Interior Of A Protein To The Conformational Stability Length = 130 Back     alignment and structure
>pdb|1CKC|A Chain A, T43a Mutant Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1GF9|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|1B5X|A Chain A, Contribution Of Hydrogen Bonds To The Conformational Stability Of Human Lysozyme: Calorimetry And X-Ray Analysis Of Six Ser->ala Mutants Length = 130 Back     alignment and structure
>pdb|1B7O|A Chain A, Verification Of Spmp Using Mutant Human Lysozymes Length = 130 Back     alignment and structure
>pdb|1OUH|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: X-Ray Structure Of The V74a Mutant Length = 130 Back     alignment and structure
>pdb|1EQE|A Chain A, Crystal Structures Of Salt Bridge Mutants Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1GB0|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|1GE0|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At Left-Handed Helical Positions Length = 130 Back     alignment and structure
>pdb|1GFR|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|1GB6|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|1GAY|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|133L|A Chain A, Role Of Arg 115 In The Catalytic Action Of Human Lysozyme. X-Ray Structure Of His 115 And Glu 115 Mutants Length = 130 Back     alignment and structure
>pdb|1EQ5|A Chain A, Crystal Structures Of Salt Bridge Mutants Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1GBY|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|1B7Q|A Chain A, Verification Of Spmp Using Mutant Human Lysozymes Length = 130 Back     alignment and structure
>pdb|1GB7|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|1GB9|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|1LZS|A Chain A, Structural Changes Of The Active Site Cleft And Different Saccharide Binding Modes In Human Lysozyme Co-Crystallized With Hexa-N-Acetyl- Chitohexaose At Ph 4.0 Length = 130 Back     alignment and structure
>pdb|1OUF|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: X-Ray Structure Of The V130a Mutant Length = 130 Back     alignment and structure
>pdb|1OUE|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: X-Ray Structure Of The V125a Mutant Length = 130 Back     alignment and structure
>pdb|1GB8|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|1GFK|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|1LYY|A Chain A, Amyloidogenic Variant (Asp67his) Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1IP7|A Chain A, G129a Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1CKH|A Chain A, T70v Mutant Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1CKG|A Chain A, T52v Mutant Human Lysozyme Length = 130 Back     alignment and structure
>pdb|134L|A Chain A, Role Of Arg 115 In The Catalytic Action Of Human Lysozyme. X-Ray Structure Of His 115 And Glu 115 Mutants Length = 130 Back     alignment and structure
>pdb|1CKD|A Chain A, T43v Mutant Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1GFH|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|1B7S|A Chain A, Verification Of Spmp Using Mutant Human Lysozymes Length = 130 Back     alignment and structure
>pdb|1WQP|A Chain A, Contribution Of Hydrogen Bonds To The Conformational Stability Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1GFT|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|1GB3|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|1WQN|A Chain A, Contribution Of Hydrogen Bonds To The Conformational Stability Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1GAZ|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|1LHL|A Chain A, Role Of Proline Residues In Human Lysozyme Stability: A Scanning Calorimetric Study Combined With X-Ray Structure Analysis Of Proline Mutants Length = 130 Back     alignment and structure
>pdb|1B5W|A Chain A, Contribution Of Hydrogen Bonds To The Conformational Stability Of Human Lysozyme: Calorimetry And X-Ray Analysis Of Six Ser->ala Mutants Length = 130 Back     alignment and structure
>pdb|1GBW|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|1WQO|A Chain A, Contribution Of Hydrogen Bonds To The Conformational Stability Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1GBZ|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|1YAM|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: Calorimetric Studies And X-Ray Structural Analysis Of The Five Isoleucine To Valine Mutants Length = 130 Back     alignment and structure
>pdb|1GBX|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At The Surface Positions Length = 130 Back     alignment and structure
>pdb|1W08|A Chain A, Structure Of T70n Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1IP4|A Chain A, G72a Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1IP1|A Chain A, G37a Human Lysozyme Length = 130 Back     alignment and structure
>pdb|2HEB|A Chain A, Contribution Of Water Molecules In The Interior Of A Protein To The Conformational Stability Length = 130 Back     alignment and structure
>pdb|1GDW|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At Left-Handed Helical Positions Length = 130 Back     alignment and structure
>pdb|1YAO|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: Calorimetric Studies And X-Ray Structural Analysis Of The Five Isoleucine To Valine Mutants Length = 130 Back     alignment and structure
>pdb|1YAP|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: Calorimetric Studies And X-Ray Structural Analysis Of The Five Isoleucine To Valine Mutants Length = 130 Back     alignment and structure
>pdb|1YAN|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: Calorimetric Studies And X-Ray Structural Analysis Of The Five Isoleucine To Valine Mutants Length = 130 Back     alignment and structure
>pdb|1YAQ|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: Calorimetric Studies And X-Ray Structural Analysis Of The Five Isoleucine To Valine Mutants Length = 130 Back     alignment and structure
>pdb|1GF5|A Chain A, Buried Polar Mutant Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1B5Y|A Chain A, Contribution Of Hydrogen Bonds To The Conformational Stability Of Human Lysozyme: Calorimetry And X-Ray Analysis Of Six Ser->ala Mutants Length = 130 Back     alignment and structure
>pdb|1B5V|A Chain A, Contribution Of Hydrogen Bonds To The Conformational Stability Of Human Lysozyme: Calorimetry And X-Ray Analysis Of Six Ser->ala Mutants Length = 130 Back     alignment and structure
>pdb|1C43|A Chain A, Mutant Human Lysozyme With Foreign N-Terminal Residues Length = 130 Back     alignment and structure
>pdb|1B5Z|A Chain A, Contribution Of Hydrogen Bonds To The Conformational Stability Of Human Lysozyme: Calorimetry And X-Ray Analysis Of Six Ser->ala Mutants Length = 130 Back     alignment and structure
>pdb|1CJ9|A Chain A, T40v Mutant Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1C45|A Chain A, Mutant Human Lysozyme With Foreign N-Terminal Residues Length = 130 Back     alignment and structure
>pdb|1JKC|A Chain A, Human Lysozyme Mutant With Trp 109 Replaced By Phe Length = 130 Back     alignment and structure
>pdb|1WQQ|A Chain A, Contribution Of Hydrogen Bonds To The Conformational Stability Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|2MEE|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|2MEB|A Chain A, Changes In Conformational Stability Of A Series Of Mutant Human Lysozymes At Constant Positions Length = 130 Back     alignment and structure
>pdb|2MEF|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|2MEC|A Chain A, Changes In Conformational Stability Of A Series Of Mutant Human Lysozymes At Constant Positions Length = 130 Back     alignment and structure
>pdb|1GF0|A Chain A, Buried Polar Mutant Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1GEZ|A Chain A, Buried Polar Mutant Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1LZ5|A Chain A, Structural And Functional Analyses Of The Arg-Gly-Asp Sequence Introduced Into Human Lysozyme Length = 134 Back     alignment and structure
>pdb|1EQ4|A Chain A, Crystal Structures Of Salt Bridge Mutants Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1GE3|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At Left-Handed Helical Positions Length = 130 Back     alignment and structure
>pdb|1GE4|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At Left-Handed Helical Positions Length = 130 Back     alignment and structure
>pdb|1JKA|A Chain A, Human Lysozyme Mutant With Glu 35 Replaced By Asp Length = 130 Back     alignment and structure
>pdb|1TCY|A Chain A, Dissection Of The Functional Role Of Structural Elements Of Tyrosine-63 In The Catalytic Action Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1WQM|A Chain A, Contribution Of Hydrogen Bonds To The Conformational Stability Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1GF6|A Chain A, Buried Polar Mutant Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1IP5|A Chain A, G105a Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1OUJ|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: X-Ray Structure Of The V99a Mutant Length = 130 Back     alignment and structure
>pdb|1OUI|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: X-Ray Structure Of The V93a Mutant Length = 130 Back     alignment and structure
>pdb|1OUD|A Chain A, Contribution Of Hydrophobic Residues To The Stability Of Human Lysozyme: X-Ray Structure Of The V121a Mutant Length = 130 Back     alignment and structure
>pdb|1GF4|A Chain A, Buried Polar Mutant Human Lysozyme Length = 130 Back     alignment and structure
>pdb|2MEA|A Chain A, Changes In Conformational Stability Of A Series Of Mutant Human Lysozymes At Constant Positions Length = 130 Back     alignment and structure
>pdb|2MED|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1TDY|A Chain A, Dissection Of The Functional Role Of Structural Elements Of Tyrosine-63 In The Catalytic Action Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1LAA|A Chain A, X-Ray Structure Of Glu 53 Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1DI5|A Chain A, Role Of Amino Acid Residues At Turns In The Conformational Stability And Folding Of Human Lysozyme Length = 129 Back     alignment and structure
>pdb|1B7L|A Chain A, Verification Of Spmp Using Mutant Human Lysozymes Length = 130 Back     alignment and structure
>pdb|2MEH|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1LOZ|A Chain A, Amyloidogenic Variant (I56t) Variant Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1GEV|A Chain A, Buried Polar Mutant Human Lysozyme Length = 130 Back     alignment and structure
>pdb|2HEC|A Chain A, Contribution Of Water Molecules In The Interior Of A Protein To The Conformational Stability Length = 130 Back     alignment and structure
>pdb|2HEF|A Chain A, Contribution Of Water Molecules In The Interior Of A Protein To The Conformational Stability Length = 130 Back     alignment and structure
>pdb|2HED|A Chain A, Contribution Of Water Molecules In The Interior Of A Protein To The Conformational Stability Length = 130 Back     alignment and structure
>pdb|1IP2|A Chain A, G48a Human Lysozyme Length = 130 Back     alignment and structure
>pdb|2MEI|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1JKB|A Chain A, Human Lysozyme Mutant With Glu 35 Replaced By Ala Length = 130 Back     alignment and structure
>pdb|1GE1|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At Left-Handed Helical Positions Length = 130 Back     alignment and structure
>pdb|1BB4|A Chain A, Human Lysozyme Double Mutant A96l, W109h Length = 130 Back     alignment and structure
>pdb|1D6P|A Chain A, Human Lysozyme L63 Mutant Labelled With 2',3'-Epoxypropyl N,N'- Diacetylchitobiose Length = 130 Back     alignment and structure
>pdb|1B7R|A Chain A, Verification Of Spmp Using Mutant Human Lysozymes Length = 130 Back     alignment and structure
>pdb|2MEG|A Chain A, Changes In Conformational Stability Of A Series Of Mutant Human Lysozymes At Constant Positions Length = 130 Back     alignment and structure
>pdb|1LZ6|A Chain A, Structural And Functional Analyses Of The Arg-Gly-Asp Sequence Introduced Into Human Lysozyme Length = 138 Back     alignment and structure
>pdb|1LMT|A Chain A, Structure Of A Conformationally Constrained Arg-Gly-Asp Sequence Inserted Into Human Lysozyme Length = 136 Back     alignment and structure
>pdb|208L|A Chain A, Mutant Human Lysozyme C77a Length = 130 Back     alignment and structure
>pdb|1LHK|A Chain A, Role Of Proline Residues In Human Lysozyme Stability: A Scanning Calorimetric Study Combined With X-Ray Structure Analysis Of Proline Mutants Length = 130 Back     alignment and structure
>pdb|1B7N|A Chain A, Verification Of Spmp Using Mutant Human Lysozymes Length = 130 Back     alignment and structure
>pdb|1JKD|A Chain A, Human Lysozyme Mutant With Trp 109 Replaced By Ala Length = 130 Back     alignment and structure
>pdb|2HEE|A Chain A, Contribution Of Water Molecules In The Interior Of A Protein To The Conformational Stability Length = 130 Back     alignment and structure
>pdb|1TAY|A Chain A, Dissection Of The Functional Role Of Structural Elements Of Tyrosine-63 In The Catalytic Action Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1GE2|A Chain A, Crystal Structure Of Mutant Human Lysozyme Substituted At Left-Handed Helical Positions Length = 130 Back     alignment and structure
>pdb|1B7P|A Chain A, Verification Of Spmp Using Mutant Human Lysozymes Length = 130 Back     alignment and structure
>pdb|2BQH|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1GHL|A Chain A, The Three-Dimensional Structure Of Pheasant And Guinea-Fowl Egg Lysozymes Length = 130 Back     alignment and structure
>pdb|2BQL|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1DI4|A Chain A, Role Of Amino Acid Residues At Turns In The Conformational Stability And Folding Of Human Lysozyme Length = 128 Back     alignment and structure
>pdb|2BQM|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1LHM|A Chain A, The Crystal Structure Of A Mutant Lysozyme C77(Slash)95a With Increased Secretion Efficiency In Yeast Length = 130 Back     alignment and structure
>pdb|2BQK|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|2BQJ|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1IOR|A Chain A, Stabilization Of Hen Egg White Lysozyme By A Cavity-Filling Mutation Length = 129 Back     alignment and structure
>pdb|2BQB|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|2BQD|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|2BQE|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|2BQC|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1LZD|A Chain A, Dissection Of Protein-Carbohydrate Interactions In Mutant Hen Egg-White Lysozyme Complexes And Their Hydrolytic Activity Length = 129 Back     alignment and structure
>pdb|2BQI|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1HER|A Chain A, Structural And Thermodynamic Analysis Of Compensating Mutations Within The Core Of Chicken Egg White Lysozyme Length = 129 Back     alignment and structure
>pdb|1IOQ|A Chain A, Stabilization Of Hen Egg White Lysozyme By A Cavity-Filling Mutation Length = 129 Back     alignment and structure
>pdb|1NBY|C Chain C, Crystal Structure Of Hyhel-63 Complexed With Hel Mutant K96a Length = 129 Back     alignment and structure
>pdb|1IOT|A Chain A, Stabilization Of Hen Egg White Lysozyme By A Cavity-Filling Mutation Length = 129 Back     alignment and structure
>pdb|1QSW|A Chain A, Crystal Structure Analysis Of A Human Lysozyme Mutant W64c C65a Length = 130 Back     alignment and structure
>pdb|1HEQ|A Chain A, Structural And Thermodynamic Analysis Of Compensating Mutations Within The Core Of Chicken Egg White Lysozyme Length = 129 Back     alignment and structure
>pdb|1IX0|A Chain A, I59a-3ss Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1FLU|A Chain A, Hen Egg White Lysozyme Mutant With Alanine Substituted For Glycine Length = 129 Back     alignment and structure
>pdb|132L|A Chain A, Structural Consequences Of Reductive Methylation Of Lysine Residues In Hen Egg White Lysozyme: An X-Ray Analysis At 1.8 Angstroms Resolution Length = 129 Back     alignment and structure
>pdb|1A2Y|C Chain C, Hen Egg White Lysozyme, D18a Mutant, In Complex With Mouse Monoclonal Antibody D1.3 Length = 129 Back     alignment and structure
>pdb|1FLW|A Chain A, Hen Egg White Lysozyme Mutant With Alanine Substituted For Glycine Length = 129 Back     alignment and structure
>pdb|1BQL|Y Chain Y, Structure Of An Anti-Hel Fab Fragment Complexed With Bobwhite Quail Lysozyme Length = 129 Back     alignment and structure
>pdb|1IR7|A Chain A, Im Mutant Of Lysozyme Length = 129 Back     alignment and structure
>pdb|2IFF|Y Chain Y, Structure Of An Antibody-Lysozyme Complex: Effect Of A Conservative Mutation Length = 129 Back     alignment and structure
>pdb|1KXX|A Chain A, Analysis Of The Stabilization Of Hen Lysozyme With The Helix Dipole And Charged Side Chains Length = 129 Back     alignment and structure
>pdb|1KXW|A Chain A, Analysis Of The Stabilization Of Hen Lysozyme With The Helix Dipole And Charged Side Chains Length = 129 Back     alignment and structure
>pdb|1UIA|A Chain A, Analysis Of The Stabilization Of Hen Lysozyme With The Helix Dipole And Charged Side Chains Length = 127 Back     alignment and structure
>pdb|1HEP|A Chain A, Structural And Thermodynamic Analysis Of Compensating Mutations Within The Core Of Chicken Egg White Lysozyme Length = 129 Back     alignment and structure
>pdb|1LZG|A Chain A, Dissection Of Protein-Carbohydrate Interactions In Mutant Hen Egg- White Lysozyme Complexes And Their Hydrolytic Activity Length = 129 Back     alignment and structure
>pdb|1JHL|A Chain A, Three-Dimensional Structure Of A Heteroclitic Antigen- Antibody Cross-Reaction Complex Length = 129 Back     alignment and structure
>pdb|1FLQ|A Chain A, Hen Egg White Lysozyme Mutant With Alanine Substituted For Glycine Length = 129 Back     alignment and structure
>pdb|1FBI|X Chain X, Crystal Structure Of A Cross-Reaction Complex Between Fab F9.13.7 And Guinea-Fowl Lysozyme Length = 129 Back     alignment and structure
>pdb|1FDL|Y Chain Y, Crystallographic Refinement Of The Three-Dimensional Structure Of The Fab D1.3-Lysozyme Complex At 2.5- Angstroms Resolution Length = 129 Back     alignment and structure
>pdb|1UIC|A Chain A, Analysis Of The Stabilization Of Hen Lysozyme With The Helix Dipole And Charged Side Chains Length = 129 Back     alignment and structure
>pdb|1KXY|A Chain A, Analysis Of The Stabilization Of Hen Lysozyme With The Helix Dipole And Charged Side Chains Length = 129 Back     alignment and structure
>pdb|1HEM|A Chain A, Structural And Thermodynamic Analysis Of Compensating Mutations Within The Core Of Chicken Egg White Lysozyme Length = 129 Back     alignment and structure
>pdb|1AT6|A Chain A, Hen Egg White Lysozyme With A Isoaspartate Residue Length = 129 Back     alignment and structure
>pdb|1V7S|A Chain A, Triclinic Hen Lysozyme Crystallized At 313k From A D2o Solution Length = 129 Back     alignment and structure
>pdb|1UID|A Chain A, Analysis Of The Stabilization Of Hen Lysozyme With The Helix Dipole And Charged Side Chains Length = 129 Back     alignment and structure
>pdb|1LSG|A Chain A, Three-Dimensional Structure Of The Platelet Integrin Recognition Segment Of The Fibrinogen Gamma Chain Obtained By Carrier Protein-Driven Crystallization Length = 144 Back     alignment and structure
>pdb|1LSN|A Chain A, Thermal Stability Determinants Of Chicken Egg-White Lysozyme Core Mutants: Hydrophobicity, Packing Volume And Conserved Buried Water Molecules Length = 129 Back     alignment and structure
>pdb|1UIF|A Chain A, Analysis Of The Stabilization Of Hen Lysozyme With The Helix Dipole And Charged Side Chains Length = 129 Back     alignment and structure
>pdb|1UIE|A Chain A, Analysis Of The Stabilization Of Hen Lysozyme With The Helix Dipole And Charged Side Chains Length = 129 Back     alignment and structure
>pdb|3QY4|A Chain A, Crystallization And In Situ Data Collection Of Lysozyme Using The Crystal Former Length = 129 Back     alignment and structure
>pdb|1HEO|A Chain A, Structural And Thermodynamic Analysis Of Compensating Mutations Within The Core Of Chicken Egg White Lysozyme Length = 129 Back     alignment and structure
>pdb|1IVM|A Chain A, Solution Structure Of Mouse Lysozyme M Length = 130 Back     alignment and structure
>pdb|1IO5|A Chain A, Hydrogen And Hydration Of Hen Egg-White Lysozyme Determined By Neutron Diffraction Length = 129 Back     alignment and structure
>pdb|1HEN|A Chain A, Structural And Thermodynamic Analysis Of Compensating Mutations Within The Core Of Chicken Egg White Lysozyme Length = 129 Back     alignment and structure
>pdb|1IOS|A Chain A, Stabilization Of Hen Egg White Lysozyme By A Cavity-Filling Mutation Length = 129 Back     alignment and structure
>pdb|1IR9|A Chain A, Im Mutant Of Lysozyme Length = 129 Back     alignment and structure
>pdb|1IR8|A Chain A, Im Mutant Of Lysozyme Length = 129 Back     alignment and structure
>pdb|1LSM|A Chain A, Thermal Stability Determinants Of Chicken Egg-White Lysozyme Core Mutants: Hydrophobicity, Packing Volume And Conserved Buried Water Molecules Length = 129 Back     alignment and structure
>pdb|1NDG|C Chain C, Crystal Structure Of Fab Fragment Of Antibody Hyhel-8 Complexed With Its Antigen Lysozyme Length = 129 Back     alignment and structure
>pdb|1H6M|A Chain A, Covalent Glycosyl-Enzyme Intermediate Of Hen Egg White Lysozyme Length = 129 Back     alignment and structure
>pdb|1DZB|X Chain X, Crystal Structure Of Phage Library-Derived Single-Chain Fv Fragment 1f9 In Complex With Turkey Egg-White Lysozyme Length = 129 Back     alignment and structure
>pdb|1HHL|A Chain A, The Three-Dimensional Structure Of Pheasant And Guinea-Fowl Egg Lysozymes Length = 129 Back     alignment and structure
>pdb|3A3Q|A Chain A, Structure Of N59d Hen Egg-White Lysozyme In Complex With (Glcnac)3 Length = 129 Back     alignment and structure
>pdb|3OJP|A Chain A, D52n Mutant Of Hen Egg White Lysozyme (Hewl) Length = 129 Back     alignment and structure
>pdb|1FLY|A Chain A, Hen Egg White Lysozyme Mutant With Alanine Substituted For Glycine Length = 129 Back     alignment and structure
>pdb|1NBZ|C Chain C, Crystal Structure Of Hyhel-63 Complexed With Hel Mutant K97a Length = 129 Back     alignment and structure
>pdb|1LZ2|A Chain A, Crystallographic Study Of Turkey Egg-White Lysozyme And Its Complex With A Disaccharide Length = 129 Back     alignment and structure
>pdb|1FN5|A Chain A, Hen Egg White Lysozyme Mutant With Alanine Substituted For Glycine Length = 129 Back     alignment and structure
>pdb|3OK0|A Chain A, E35a Mutant Of Hen Egg White Lysozyme (Hewl) Length = 129 Back     alignment and structure
>pdb|1AT5|A Chain A, Hen Egg White Lysozyme With A Succinimide Residue Length = 129 Back     alignment and structure
>pdb|1BB6|A Chain A, Lysozyme Complex With 4-Methyl-Umbelliferyl Chitotriose Length = 129 Back     alignment and structure
>pdb|2Z2F|A Chain A, X-Ray Crystal Structure Of Bovine Stomach Lysozyme Length = 129 Back     alignment and structure
>pdb|2BQN|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|2IHL|A Chain A, Lysozyme (e.c.3.2.1.17) (japanese Quail) Length = 129 Back     alignment and structure
>pdb|2GV0|A Chain A, The Structure Of The Orthorhombic Form Of Soft-Shelled Turtle Lysozyme At 1.9 Angstroms Resolution Length = 131 Back     alignment and structure
>pdb|2BQO|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|2BQG|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1HML|A Chain A, Alpha_lactalbumin Possesses A Distinct Zinc Binding Site Length = 142 Back     alignment and structure
>pdb|2BQF|A Chain A, Contribution Of Hydrophobic Effect To The Conformational Stability Of Human Lysozyme Length = 130 Back     alignment and structure
>pdb|1HFZ|A Chain A, Alpha-Lactalbumin Length = 124 Back     alignment and structure
>pdb|1F6R|A Chain A, Crystal Structure Of Apo-Bovine Alpha-Lactalbumin Length = 123 Back     alignment and structure
>pdb|1FKV|A Chain A, Recombinant Goat Alpha-Lactalbumin T29i Length = 124 Back     alignment and structure
>pdb|1FKQ|A Chain A, Recombinant Goat Alpha-Lactalbumin T29v Length = 124 Back     alignment and structure
>pdb|2GOI|A Chain A, Crystal Structure Of Mouse Sperm C-Type Lysozyme-Like Protein 1 Length = 138 Back     alignment and structure
>pdb|1A4V|A Chain A, Alpha-Lactalbumin Length = 123 Back     alignment and structure
>pdb|3B0I|A Chain A, Crystal Structure Of Recombinant Human Alpha Lactalbumin Length = 124 Back     alignment and structure
>pdb|1HMK|A Chain A, Recombinant Goat Alpha-Lactalbumin Length = 124 Back     alignment and structure
>pdb|1HFY|A Chain A, Alpha-Lactalbumin Length = 123 Back     alignment and structure
>pdb|3B0K|A Chain A, Crystal Structure Of Alpha-Lactalbumin Length = 123 Back     alignment and structure
>pdb|1ALC|A Chain A, Refined Structure Of Baboon Alpha-Lactalbumin At 1.7 Angstroms Resolution. Comparison With C-Type Lysozyme Length = 123 Back     alignment and structure
>pdb|1B9O|A Chain A, Human Alpha-Lactalbumin, Low Temperature Form Length = 123 Back     alignment and structure
>pdb|3B0O|A Chain A, Crystal Structure Of Alpha-Lactalbumin Length = 123 Back     alignment and structure
>pdb|1JUG|A Chain A, Lysozyme From Echidna Milk (Tachyglossus Aculeatus) Length = 125 Back     alignment and structure
>pdb|3ZVQ|A Chain A, Crystal Structure Of Proteolyzed Lysozyme Length = 70 Back     alignment and structure
>pdb|2VJ3|A Chain A, Human Notch-1 Egfs 11-13 Length = 135 Back     alignment and structure
>pdb|1TOZ|A Chain A, Nmr Structure Of The Human Notch-1 Ligand Binding Region Length = 116 Back     alignment and structure

Structure Templates Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query769
1iiz_A120 Lysozyme; hydrolase; 2.40A {Antheraea mylitta} SCO 2e-31
1iiz_A120 Lysozyme; hydrolase; 2.40A {Antheraea mylitta} SCO 1e-15
2fbd_A122 Lysozyme 1; digestive lysozime, hydrolase; HET: PE 2e-30
2fbd_A122 Lysozyme 1; digestive lysozime, hydrolase; HET: PE 8e-15
1qqy_A130 Lysozyme C; APO-type protein, calcium binding lyso 3e-28
1qqy_A130 Lysozyme C; APO-type protein, calcium binding lyso 4e-14
1hml_A142 Alpha-lactalbumin; calcium-binding protein; 1.70A 5e-28
1hml_A142 Alpha-lactalbumin; calcium-binding protein; 1.70A 3e-12
3b72_A147 Lysozyme C; hen egg-white lysozyme, protein-SDS co 9e-28
3b72_A147 Lysozyme C; hen egg-white lysozyme, protein-SDS co 8e-14
2gv0_A131 Lysozyme C; hydrolase; 1.90A {Pelodiscus sinensis} 2e-27
2gv0_A131 Lysozyme C; hydrolase; 1.90A {Pelodiscus sinensis} 2e-13
2goi_A138 Sperm lysozyme-like protein 1; mouse SLLP1, MSLLP1 2e-27
2goi_A138 Sperm lysozyme-like protein 1; mouse SLLP1, MSLLP1 2e-14
1yro_A123 Alpha-lactalbumin; Arg228Lys mutation, UDP-GAL com 2e-27
1yro_A123 Alpha-lactalbumin; Arg228Lys mutation, UDP-GAL com 1e-13
2nwd_X130 Lysozyme C; native chemical ligation, chemical pro 8e-27
2nwd_X130 Lysozyme C; native chemical ligation, chemical pro 4e-13
2z2f_A129 Lysozyme C-2; stomach lysozyme, 1,4-beta-N-acetylm 1e-26
2z2f_A129 Lysozyme C-2; stomach lysozyme, 1,4-beta-N-acetylm 8e-13
1b9o_A123 Protein (alpha-lactalbumin); calcium-binding prote 1e-26
1b9o_A123 Protein (alpha-lactalbumin); calcium-binding prote 6e-13
1jug_A125 Lysozyme; calcium-binding; 1.90A {Tachyglossus acu 1e-26
1jug_A125 Lysozyme; calcium-binding; 1.90A {Tachyglossus acu 8e-14
1lsg_A144 Hen egg white lysozyme; fibrinogen, hybrid protein 3e-26
1lsg_A144 Hen egg white lysozyme; fibrinogen, hybrid protein 5e-14
2vb1_A129 Lysozyme C; antimicrobial, triclinic HEWL, atomic 5e-26
2vb1_A129 Lysozyme C; antimicrobial, triclinic HEWL, atomic 9e-14
1lmq_A129 Lysozyme; hydrolase (O-glycosyl); HET: NAG NDG; 1. 8e-26
1lmq_A129 Lysozyme; hydrolase (O-glycosyl); HET: NAG NDG; 1. 6e-13
2vj3_A135 Neurogenic locus notch homolog protein 1; transcri 8e-14
2vj3_A135 Neurogenic locus notch homolog protein 1; transcri 8e-09
2vh0_B134 Activated factor XA light chain; serine protease, 3e-13
2vh0_B134 Activated factor XA light chain; serine protease, 3e-10
4d90_A143 EGF-like repeat and discoidin I-like domain-conta 3e-12
4d90_A143 EGF-like repeat and discoidin I-like domain-conta 4e-10
4d90_A143 EGF-like repeat and discoidin I-like domain-conta 2e-06
4d90_A143 EGF-like repeat and discoidin I-like domain-conta 6e-05
4d90_A143 EGF-like repeat and discoidin I-like domain-conta 7e-04
1nfu_B195 Coagulation factor XA, light chain; hydrolase; HET 1e-11
1nfu_B195 Coagulation factor XA, light chain; hydrolase; HET 2e-11
1nfu_B195 Coagulation factor XA, light chain; hydrolase; HET 5e-09
2vj2_A169 Jagged-1; signalling, polymorphism, glycoprotein, 8e-11
2vj2_A169 Jagged-1; signalling, polymorphism, glycoprotein, 9e-07
2vj2_A169 Jagged-1; signalling, polymorphism, glycoprotein, 1e-06
2ygq_A324 WIF-1, WNT inhibitory factor 1; signaling protein, 4e-09
2ygq_A324 WIF-1, WNT inhibitory factor 1; signaling protein, 2e-08
2ygq_A324 WIF-1, WNT inhibitory factor 1; signaling protein, 2e-08
2ygq_A324 WIF-1, WNT inhibitory factor 1; signaling protein, 2e-08
2ygq_A 324 WIF-1, WNT inhibitory factor 1; signaling protein, 2e-04
1x7a_L146 Coagulation factor IX, light chain; inhibition, bl 2e-08
1x7a_L146 Coagulation factor IX, light chain; inhibition, bl 3e-08
2c4f_L142 Coagulation factor VII precursor; blood coagulatio 5e-07
2c4f_L142 Coagulation factor VII precursor; blood coagulatio 3e-04
2gy5_A423 Angiopoietin-1 receptor; ligand-binding domain, tr 6e-07
2gy5_A423 Angiopoietin-1 receptor; ligand-binding domain, tr 9e-06
2gy5_A 423 Angiopoietin-1 receptor; ligand-binding domain, tr 2e-05
2gy5_A 423 Angiopoietin-1 receptor; ligand-binding domain, tr 3e-04
1uzk_A162 Fibrillin-1; glycoprotein, extra-cellular matrix, 2e-06
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 4e-06
1tpg_A91 T-plasminogen activator F1-G; plasminogen activati 4e-06
1tpg_A91 T-plasminogen activator F1-G; plasminogen activati 1e-05
1aut_L114 Activated protein C; serine proteinase, plasma cal 5e-06
1aut_L114 Activated protein C; serine proteinase, plasma cal 2e-05
3fcs_B690 Integrin beta-3; beta propeller, rossmann fold, EG 3e-05
3k6s_B687 Integrin beta-2; cell receptor, adhesion molecule, 1e-04
3k6s_B687 Integrin beta-2; cell receptor, adhesion molecule, 7e-04
1edm_B39 Factor IX; epidermal growth factor, EGF, calcium- 2e-04
1edm_B39 Factor IX; epidermal growth factor, EGF, calcium- 5e-04
3zyj_B426 Netrin-G1; cell adhesion, synapse; HET: NAG BMA MA 4e-04
3h5c_B317 Vitamin K-dependent protein Z; protein Z-protein Z 4e-04
1b9w_A95 Protein (merozoite surface protein 1); MSP-1, cand 4e-04
2bou_A143 EGF-like module containing mucin-like hormone rece 5e-04
1ob1_C99 Major merozoite surface protein; immune system, im 5e-04
>1iiz_A Lysozyme; hydrolase; 2.40A {Antheraea mylitta} SCOP: d.2.1.2 PDB: 1gd6_A Length = 120 Back     alignment and structure
 Score =  117 bits (295), Expect = 2e-31
 Identities = 46/118 (38%), Positives = 64/118 (54%), Gaps = 8/118 (6%)

Query: 279 KRFGACELAKFLVRQRGIARRDVPTWVCIATKESNRNSNARSPKNGNGSRDHGIFQINDK 338
           KRF  C L   L +Q G     +  WVC+   ES R ++  +  N NGSRD+G+FQINDK
Sbjct: 1   KRFTRCGLVNELRKQ-GFDENLMRDWVCLVENESARYTDKIANVNKNGSRDYGLFQINDK 59

Query: 339 YWCTASGPAGKECHAKCSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTY-HYCN 395
           YWC+     GK+C+  CS    ++IT    C  KI+ +        F AWS + ++CN
Sbjct: 60  YWCSKGSTPGKDCNVTCSQLLTDDITVASTCAKKIYKR------TKFDAWSGWDNHCN 111


>1iiz_A Lysozyme; hydrolase; 2.40A {Antheraea mylitta} SCOP: d.2.1.2 PDB: 1gd6_A Length = 120 Back     alignment and structure
>2fbd_A Lysozyme 1; digestive lysozime, hydrolase; HET: PEG; 1.90A {Musca domestica} PDB: 2h5z_A* 3cb7_A Length = 122 Back     alignment and structure
>2fbd_A Lysozyme 1; digestive lysozime, hydrolase; HET: PEG; 1.90A {Musca domestica} PDB: 2h5z_A* 3cb7_A Length = 122 Back     alignment and structure
>1qqy_A Lysozyme C; APO-type protein, calcium binding lysozyme, enzyme, hydrolase; 1.85A {Canis lupus familiaris} SCOP: d.2.1.2 PDB: 1el1_A 1i56_A 2cwi_A 2z2e_A 2eql_A Length = 130 Back     alignment and structure
>1qqy_A Lysozyme C; APO-type protein, calcium binding lysozyme, enzyme, hydrolase; 1.85A {Canis lupus familiaris} SCOP: d.2.1.2 PDB: 1el1_A 1i56_A 2cwi_A 2z2e_A 2eql_A Length = 130 Back     alignment and structure
>1hml_A Alpha-lactalbumin; calcium-binding protein; 1.70A {Homo sapiens} SCOP: d.2.1.2 Length = 142 Back     alignment and structure
>1hml_A Alpha-lactalbumin; calcium-binding protein; 1.70A {Homo sapiens} SCOP: d.2.1.2 Length = 142 Back     alignment and structure
>3b72_A Lysozyme C; hen egg-white lysozyme, protein-SDS complex, MPD, allergen, antimicrobial, bacteriolytic enzyme glycosidase, hydrolase; 1.50A {Gallus gallus} SCOP: d.2.1.2 PDB: 3b6l_A 1lsy_A 1lsz_A* Length = 147 Back     alignment and structure
>3b72_A Lysozyme C; hen egg-white lysozyme, protein-SDS complex, MPD, allergen, antimicrobial, bacteriolytic enzyme glycosidase, hydrolase; 1.50A {Gallus gallus} SCOP: d.2.1.2 PDB: 3b6l_A 1lsy_A 1lsz_A* Length = 147 Back     alignment and structure
>2gv0_A Lysozyme C; hydrolase; 1.90A {Pelodiscus sinensis} Length = 131 Back     alignment and structure
>2gv0_A Lysozyme C; hydrolase; 1.90A {Pelodiscus sinensis} Length = 131 Back     alignment and structure
>2goi_A Sperm lysozyme-like protein 1; mouse SLLP1, MSLLP1, sperm C-type lysozyme-like protein 1, acrosomal sperm protein, sperm-egg binding, fertilization; 2.30A {Mus musculus} Length = 138 Back     alignment and structure
>2goi_A Sperm lysozyme-like protein 1; mouse SLLP1, MSLLP1, sperm C-type lysozyme-like protein 1, acrosomal sperm protein, sperm-egg binding, fertilization; 2.30A {Mus musculus} Length = 138 Back     alignment and structure
>1yro_A Alpha-lactalbumin; Arg228Lys mutation, UDP-GAL complex, transferase activator/transferase complex; HET: GDU UDP MES PG4; 1.90A {Mus musculus} SCOP: d.2.1.2 PDB: 1nhe_A* 1nkh_A* 1nmm_A* 1nqi_A* 1nwg_A* 1o23_A* 1oqm_A* 1pzy_A* 1nf5_A* 2fyc_A* 2fyd_A* Length = 123 Back     alignment and structure
>1yro_A Alpha-lactalbumin; Arg228Lys mutation, UDP-GAL complex, transferase activator/transferase complex; HET: GDU UDP MES PG4; 1.90A {Mus musculus} SCOP: d.2.1.2 PDB: 1nhe_A* 1nkh_A* 1nmm_A* 1nqi_A* 1nwg_A* 1o23_A* 1oqm_A* 1pzy_A* 1nf5_A* 2fyc_A* 2fyd_A* Length = 123 Back     alignment and structure
>2nwd_X Lysozyme C; native chemical ligation, chemical protein synthesis, convergent synthesis, hydrolase; 1.04A {Synthetic} SCOP: d.2.1.2 PDB: 1iwu_A 1iwv_A 1iww_A 1iwx_A 1iwy_A 1iwz_A 1iy3_A 1iy4_A 1iwt_A 1jwr_A 1lz1_A 1lzr_A* 1lzs_A* 1op9_B 1re2_A* 1rem_A* 1rex_A 1rey_A* 1rez_A* 1jsf_A ... Length = 130 Back     alignment and structure
>2nwd_X Lysozyme C; native chemical ligation, chemical protein synthesis, convergent synthesis, hydrolase; 1.04A {Synthetic} SCOP: d.2.1.2 PDB: 1iwu_A 1iwv_A 1iww_A 1iwx_A 1iwy_A 1iwz_A 1iy3_A 1iy4_A 1iwt_A 1jwr_A 1lz1_A 1lzr_A* 1lzs_A* 1op9_B 1re2_A* 1rem_A* 1rex_A 1rey_A* 1rez_A* 1jsf_A ... Length = 130 Back     alignment and structure
>2z2f_A Lysozyme C-2; stomach lysozyme, 1,4-beta-N-acetylmuramidase C, bacteriolytic enzyme, hydrolase; 1.50A {Bos taurus} Length = 129 Back     alignment and structure
>2z2f_A Lysozyme C-2; stomach lysozyme, 1,4-beta-N-acetylmuramidase C, bacteriolytic enzyme, hydrolase; 1.50A {Bos taurus} Length = 129 Back     alignment and structure
>1b9o_A Protein (alpha-lactalbumin); calcium-binding protein, high resolution; 1.15A {Homo sapiens} SCOP: d.2.1.2 PDB: 1a4v_A 1alc_A 1hmk_A 1hfy_A 1f6r_A 1f6s_A 2g4n_A 1fkq_A 1fkv_A 1hfz_A 1hfx_A Length = 123 Back     alignment and structure
>1b9o_A Protein (alpha-lactalbumin); calcium-binding protein, high resolution; 1.15A {Homo sapiens} SCOP: d.2.1.2 PDB: 1a4v_A 1alc_A 1hmk_A 1hfy_A 1f6r_A 1f6s_A 2g4n_A 1fkq_A 1fkv_A 1hfz_A 1hfx_A Length = 123 Back     alignment and structure
>1jug_A Lysozyme; calcium-binding; 1.90A {Tachyglossus aculeatus} SCOP: d.2.1.2 Length = 125 Back     alignment and structure
>1jug_A Lysozyme; calcium-binding; 1.90A {Tachyglossus aculeatus} SCOP: d.2.1.2 Length = 125 Back     alignment and structure
>1lsg_A Hen egg white lysozyme; fibrinogen, hybrid protein; 2.40A {Gallus gallus} SCOP: d.2.1.2 Length = 144 Back     alignment and structure
>1lsg_A Hen egg white lysozyme; fibrinogen, hybrid protein; 2.40A {Gallus gallus} SCOP: d.2.1.2 Length = 144 Back     alignment and structure
>2vb1_A Lysozyme C; antimicrobial, triclinic HEWL, atomic resolution, allergen, hydrolase, glycosidase, bacteriolytic enzyme; HET: EDO; 0.65A {Gallus gallus} SCOP: d.2.1.2 PDB: 194l_A 1aki_A 1azf_A 1b0d_A* 1b2k_A 1bgi_A 1bhz_A 1bvk_C 1bvx_A 1bwh_A 1bwi_A 1bwj_A 1c08_C 1c10_A 1dpw_A 1dpx_A 1dqj_C 1e8l_A 1f0w_A 1f10_A ... Length = 129 Back     alignment and structure
>2vb1_A Lysozyme C; antimicrobial, triclinic HEWL, atomic resolution, allergen, hydrolase, glycosidase, bacteriolytic enzyme; HET: EDO; 0.65A {Gallus gallus} SCOP: d.2.1.2 PDB: 194l_A 1aki_A 1azf_A 1b0d_A* 1b2k_A 1bgi_A 1bhz_A 1bvk_C 1bvx_A 1bwh_A 1bwi_A 1bwj_A 1c08_C 1c10_A 1dpw_A 1dpx_A 1dqj_C 1e8l_A 1f0w_A 1f10_A ... Length = 129 Back     alignment and structure
>1lmq_A Lysozyme; hydrolase (O-glycosyl); HET: NAG NDG; 1.60A {Oncorhynchus mykiss} SCOP: d.2.1.2 PDB: 1bb7_A* 1lmc_A* 1bb6_A 1lmo_A* 1lmp_A* 1lmn_A* Length = 129 Back     alignment and structure
>1lmq_A Lysozyme; hydrolase (O-glycosyl); HET: NAG NDG; 1.60A {Oncorhynchus mykiss} SCOP: d.2.1.2 PDB: 1bb7_A* 1lmc_A* 1bb6_A 1lmo_A* 1lmp_A* 1lmn_A* Length = 129 Back     alignment and structure
>2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* Length = 135 Back     alignment and structure
>2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* Length = 135 Back     alignment and structure
>2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ... Length = 134 Back     alignment and structure
>2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ... Length = 134 Back     alignment and structure
>4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} Length = 143 Back     alignment and structure
>4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} Length = 143 Back     alignment and structure
>4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} Length = 143 Back     alignment and structure
>4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} Length = 143 Back     alignment and structure
>4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} Length = 143 Back     alignment and structure
>1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* Length = 195 Back     alignment and structure
>1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* Length = 195 Back     alignment and structure
>1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* Length = 195 Back     alignment and structure
>2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A Length = 169 Back     alignment and structure
>2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A Length = 169 Back     alignment and structure
>2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A Length = 169 Back     alignment and structure
>2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} Length = 324 Back     alignment and structure
>2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} Length = 324 Back     alignment and structure
>2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} Length = 324 Back     alignment and structure
>2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} Length = 324 Back     alignment and structure
>2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} Length = 324 Back     alignment and structure
>1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* Length = 146 Back     alignment and structure
>1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* Length = 146 Back     alignment and structure
>2c4f_L Coagulation factor VII precursor; blood coagulation, serine protease, EGF, EGF-like domain, GLA, receptor enzyme, glycoprotein, hydrolase, protease; HET: CGU GLC FUC NAG GIL; 1.72A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.32.1.1 PDB: 1w2k_L* 1w0y_L* 1z6j_L* 2b8o_L* 2aer_L* 2ec9_L* 2fir_L* 2a2q_L* 1fak_L* 1o5d_L* 1wqv_L* 1wss_L* 1wtg_L* 1wun_L* 1wv7_L* 1dan_L* 2aei_L* 2b7d_L* 2f9b_L* 2flb_L* ... Length = 142 Back     alignment and structure
>2c4f_L Coagulation factor VII precursor; blood coagulation, serine protease, EGF, EGF-like domain, GLA, receptor enzyme, glycoprotein, hydrolase, protease; HET: CGU GLC FUC NAG GIL; 1.72A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.32.1.1 PDB: 1w2k_L* 1w0y_L* 1z6j_L* 2b8o_L* 2aer_L* 2ec9_L* 2fir_L* 2a2q_L* 1fak_L* 1o5d_L* 1wqv_L* 1wss_L* 1wtg_L* 1wun_L* 1wv7_L* 1dan_L* 2aei_L* 2b7d_L* 2f9b_L* 2flb_L* ... Length = 142 Back     alignment and structure
>2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* Length = 423 Back     alignment and structure
>2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* Length = 423 Back     alignment and structure
>2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* Length = 423 Back     alignment and structure
>2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* Length = 423 Back     alignment and structure
>1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A Length = 162 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1tpg_A T-plasminogen activator F1-G; plasminogen activation; NMR {Homo sapiens} SCOP: g.3.11.1 g.27.1.1 PDB: 1tpm_A 1tpn_A Length = 91 Back     alignment and structure
>1tpg_A T-plasminogen activator F1-G; plasminogen activation; NMR {Homo sapiens} SCOP: g.3.11.1 g.27.1.1 PDB: 1tpm_A 1tpn_A Length = 91 Back     alignment and structure
>1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* Length = 114 Back     alignment and structure
>1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* Length = 114 Back     alignment and structure
>3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 3ije_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B* Length = 690 Back     alignment and structure
>3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Length = 687 Back     alignment and structure
>3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Length = 687 Back     alignment and structure
>1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A Length = 39 Back     alignment and structure
>1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A Length = 39 Back     alignment and structure
>3zyj_B Netrin-G1; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 426 Back     alignment and structure
>3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens} Length = 317 Back     alignment and structure
>1b9w_A Protein (merozoite surface protein 1); MSP-1, candidate malaria vaccine, surface antigen; 1.80A {Plasmodium cynomolgi} SCOP: g.3.11.4 g.3.11.4 PDB: 2npr_A Length = 95 Back     alignment and structure
>2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A Length = 143 Back     alignment and structure
>1ob1_C Major merozoite surface protein; immune system, immunoglobulin/complex, immunoglobulin, antib fragment, MSP1-19, EGF-like domain; 2.90A {Plasmodium falciparum} SCOP: g.3.11.4 g.3.11.4 PDB: 1cej_A 2flg_A Length = 99 Back     alignment and structure

Structure Templates Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query769
1hml_A142 Alpha-lactalbumin; calcium-binding protein; 1.70A 100.0
1iiz_A120 Lysozyme; hydrolase; 2.40A {Antheraea mylitta} SCO 100.0
1b9o_A123 Protein (alpha-lactalbumin); calcium-binding prote 100.0
1yro_A123 Alpha-lactalbumin; Arg228Lys mutation, UDP-GAL com 100.0
1qqy_A130 Lysozyme C; APO-type protein, calcium binding lyso 100.0
2goi_A138 Sperm lysozyme-like protein 1; mouse SLLP1, MSLLP1 100.0
2gv0_A131 Lysozyme C; hydrolase; 1.90A {Pelodiscus sinensis} 100.0
2nwd_X130 Lysozyme C; native chemical ligation, chemical pro 100.0
2z2f_A129 Lysozyme C-2; stomach lysozyme, 1,4-beta-N-acetylm 100.0
2fbd_A122 Lysozyme 1; digestive lysozime, hydrolase; HET: PE 100.0
3b72_A147 Lysozyme C; hen egg-white lysozyme, protein-SDS co 100.0
1lsg_A144 Hen egg white lysozyme; fibrinogen, hybrid protein 100.0
2vb1_A129 Lysozyme C; antimicrobial, triclinic HEWL, atomic 100.0
1jug_A125 Lysozyme; calcium-binding; 1.90A {Tachyglossus acu 100.0
1lmq_A129 Lysozyme; hydrolase (O-glycosyl); HET: NAG NDG; 1. 100.0
1iiz_A120 Lysozyme; hydrolase; 2.40A {Antheraea mylitta} SCO 99.94
1qqy_A130 Lysozyme C; APO-type protein, calcium binding lyso 99.94
2goi_A138 Sperm lysozyme-like protein 1; mouse SLLP1, MSLLP1 99.93
2gv0_A131 Lysozyme C; hydrolase; 1.90A {Pelodiscus sinensis} 99.93
2nwd_X130 Lysozyme C; native chemical ligation, chemical pro 99.93
1b9o_A123 Protein (alpha-lactalbumin); calcium-binding prote 99.93
2vb1_A129 Lysozyme C; antimicrobial, triclinic HEWL, atomic 99.93
1yro_A123 Alpha-lactalbumin; Arg228Lys mutation, UDP-GAL com 99.93
2z2f_A129 Lysozyme C-2; stomach lysozyme, 1,4-beta-N-acetylm 99.93
1hml_A142 Alpha-lactalbumin; calcium-binding protein; 1.70A 99.92
1lsg_A144 Hen egg white lysozyme; fibrinogen, hybrid protein 99.92
2fbd_A122 Lysozyme 1; digestive lysozime, hydrolase; HET: PE 99.92
3b72_A147 Lysozyme C; hen egg-white lysozyme, protein-SDS co 99.92
1lmq_A129 Lysozyme; hydrolase (O-glycosyl); HET: NAG NDG; 1. 99.91
1jug_A125 Lysozyme; calcium-binding; 1.90A {Tachyglossus acu 99.91
1z1y_A186 Ookinete surface protein PVS25; four EGF-like doma 99.8
2vj3_A135 Neurogenic locus notch homolog protein 1; transcri 99.78
2vj3_A135 Neurogenic locus notch homolog protein 1; transcri 99.76
4fbr_A267 Lectin, myxobacterial hemagglutinin; beta-barrel, 99.72
4d90_A143 EGF-like repeat and discoidin I-like domain-conta 99.69
1z1y_A186 Ookinete surface protein PVS25; four EGF-like doma 99.67
2ygq_A324 WIF-1, WNT inhibitory factor 1; signaling protein, 99.63
1yo8_A 634 Thrombospondin-2; EGF, Ca(2+)-binding domains, lec 99.62
4d90_A143 EGF-like repeat and discoidin I-like domain-conta 99.58
3fcs_B690 Integrin beta-3; beta propeller, rossmann fold, EG 99.54
1uzk_A162 Fibrillin-1; glycoprotein, extra-cellular matrix, 99.53
1yo8_A 634 Thrombospondin-2; EGF, Ca(2+)-binding domains, lec 99.53
4fbr_A267 Lectin, myxobacterial hemagglutinin; beta-barrel, 99.5
2vj2_A169 Jagged-1; signalling, polymorphism, glycoprotein, 99.5
2bou_A143 EGF-like module containing mucin-like hormone rece 99.49
2ygq_A324 WIF-1, WNT inhibitory factor 1; signaling protein, 99.49
2vj2_A169 Jagged-1; signalling, polymorphism, glycoprotein, 99.47
2bou_A143 EGF-like module containing mucin-like hormone rece 99.46
1dx5_I118 Thrombomodulin; serine proteinase, EGF-like domain 99.4
1tpg_A91 T-plasminogen activator F1-G; plasminogen activati 99.39
1dx5_I118 Thrombomodulin; serine proteinase, EGF-like domain 99.27
2w86_A147 Fibrillin-1, fibrillin1; phosphoprotein, EGF-like 99.24
3k6s_B687 Integrin beta-2; cell receptor, adhesion molecule, 99.21
1tpg_A91 T-plasminogen activator F1-G; plasminogen activati 99.16
3fcs_B690 Integrin beta-3; beta propeller, rossmann fold, EG 99.16
1emn_A82 Fibrillin; extracellular matrix, calcium-binding, 99.15
1uzk_A162 Fibrillin-1; glycoprotein, extra-cellular matrix, 99.14
1x7a_L146 Coagulation factor IX, light chain; inhibition, bl 99.04
1emn_A82 Fibrillin; extracellular matrix, calcium-binding, 99.0
2w86_A147 Fibrillin-1, fibrillin1; phosphoprotein, EGF-like 98.99
1z6c_A87 Vitamin K-dependent protein S; EGF module, blood c 98.98
2gy5_A423 Angiopoietin-1 receptor; ligand-binding domain, tr 98.97
2c4f_L142 Coagulation factor VII precursor; blood coagulatio 98.91
2c4f_L142 Coagulation factor VII precursor; blood coagulatio 98.91
1aut_L114 Activated protein C; serine proteinase, plasma cal 98.89
2gy5_A423 Angiopoietin-1 receptor; ligand-binding domain, tr 98.89
1lmj_A86 Fibrillin 1; EGF, calcium, microfibril, neonatal, 98.87
1lmj_A86 Fibrillin 1; EGF, calcium, microfibril, neonatal, 98.86
1nfu_B195 Coagulation factor XA, light chain; hydrolase; HET 98.86
1x7a_L146 Coagulation factor IX, light chain; inhibition, bl 98.84
2vh0_B134 Activated factor XA light chain; serine protease, 98.83
4aqs_A525 Laminin subunit beta-1; cell adhesion; HET: NAG BM 98.82
3k6s_B687 Integrin beta-2; cell receptor, adhesion molecule, 98.81
1z6c_A87 Vitamin K-dependent protein S; EGF module, blood c 98.79
1aut_L114 Activated protein C; serine proteinase, plasma cal 98.77
1nfu_B195 Coagulation factor XA, light chain; hydrolase; HET 98.73
3h5c_B 317 Vitamin K-dependent protein Z; protein Z-protein Z 98.71
2w2n_E107 LDL receptor, low-density lipoprotein receptor; hy 98.7
2vh0_B134 Activated factor XA light chain; serine protease, 98.68
2w2n_E107 LDL receptor, low-density lipoprotein receptor; hy 98.56
3h5c_B 317 Vitamin K-dependent protein Z; protein Z-protein Z 98.52
3u7u_G55 Neuregulin 1; signaling protein, transferase-trans 98.44
1n7d_A 699 LDL receptor, low-density lipoprotein receptor; fa 98.44
2p28_B217 Integrin beta-2; hybrid domain, PSI domain, I-EGF 98.41
3m0c_C 791 LDL receptor, low-density lipoprotein receptor; pr 98.35
1klo_A162 Laminin; glycoprotein; 2.10A {Mus musculus} SCOP: 98.34
1edm_B39 Factor IX; epidermal growth factor, EGF, calcium- 98.33
1n7d_A 699 LDL receptor, low-density lipoprotein receptor; fa 98.31
3p5b_L 400 Low density lipoprotein receptor variant; B-propel 98.3
3u7u_G55 Neuregulin 1; signaling protein, transferase-trans 98.28
3p5b_L 400 Low density lipoprotein receptor variant; B-propel 98.25
3v65_B 386 Low-density lipoprotein receptor-related protein; 98.2
3m0c_C 791 LDL receptor, low-density lipoprotein receptor; pr 98.2
2wg3_C463 Hedgehog-interacting protein; lipoprotein, develop 98.18
2k2s_B61 Micronemal protein 6; microneme protein complex, c 98.14
2p28_B217 Integrin beta-2; hybrid domain, PSI domain, I-EGF 98.12
3v65_B 386 Low-density lipoprotein receptor-related protein; 98.12
1edm_B39 Factor IX; epidermal growth factor, EGF, calcium- 98.11
1egf_A53 Epidermal growth factor; NMR {Mus musculus} SCOP: 97.99
1egf_A53 Epidermal growth factor; NMR {Mus musculus} SCOP: 97.99
1a3p_A45 Epidermal growth factor; disulfide connectivities, 97.94
1hae_A63 Heregulin-alpha; growth factor; NMR {Homo sapiens} 97.9
1hae_A63 Heregulin-alpha; growth factor; NMR {Homo sapiens} 97.85
1k36_A46 Epiregulin; EGF-like fold, hormone/growth factor c 97.79
1a3p_A45 Epidermal growth factor; disulfide connectivities, 97.78
1k36_A46 Epiregulin; EGF-like fold, hormone/growth factor c 97.72
2k2s_B61 Micronemal protein 6; microneme protein complex, c 97.72
3ca7_A52 Protein spitz; argos, EGF, developmental protein, 97.58
2wg3_C463 Hedgehog-interacting protein; lipoprotein, develop 97.56
4aqs_A525 Laminin subunit beta-1; cell adhesion; HET: NAG BM 97.52
3zyj_B426 Netrin-G1; cell adhesion, synapse; HET: NAG BMA MA 97.4
3zyj_B426 Netrin-G1; cell adhesion, synapse; HET: NAG BMA MA 97.29
1g1s_A162 P-selectin; selectin, lectin, EGF, sulphated, SLEX 97.23
1nql_B53 Epidermal growth factor; cell surface receptor, ty 97.14
1nql_B53 Epidermal growth factor; cell surface receptor, ty 97.01
1g1s_A162 P-selectin; selectin, lectin, EGF, sulphated, SLEX 96.83
3ca7_A52 Protein spitz; argos, EGF, developmental protein, 96.52
2fd6_A122 Urokinase-type plasminogen activator; UPAR, ATF, A 96.48
3ltf_D58 Protein spitz; receptor-ligand complex ectodomain 96.43
1gl4_A 285 Nidogen-1, entactin; immunoglobulin-like domain, e 96.29
1q4g_A 553 Prostaglandin G/H synthase 1; cyclooxygenase, non- 96.27
3ltf_D58 Protein spitz; receptor-ligand complex ectodomain 96.26
1ob1_C99 Major merozoite surface protein; immune system, im 96.21
3nt1_A 587 Prostaglandin-endoperoxide synthase 2; prostagland 96.13
2jkh_L55 Factor X light chain; plasma, calcium, zymogen, se 96.0
1apq_A53 Complement protease C1R; EGF, calcium binding, ser 95.99
1q4g_A 553 Prostaglandin G/H synthase 1; cyclooxygenase, non- 95.62
1gl4_A285 Nidogen-1, entactin; immunoglobulin-like domain, e 95.59
3cfw_A164 L-selectin; EGF, cell adhesion, EGF-like domain, g 95.55
1n1i_A105 Merozoite surface protein-1; MSP1, malaria, surfac 95.49
2fd6_A122 Urokinase-type plasminogen activator; UPAR, ATF, A 95.46
1kli_L69 Factor VIIA; extrinsic coagulation pathway, serine 95.37
1apq_A53 Complement protease C1R; EGF, calcium binding, ser 95.33
2kl7_A71 Fibulin-4; secreted, calcium, disease mutation, di 95.3
3nt1_A 587 Prostaglandin-endoperoxide synthase 2; prostagland 95.19
2jkh_L55 Factor X light chain; plasma, calcium, zymogen, se 95.15
1klo_A162 Laminin; glycoprotein; 2.10A {Mus musculus} SCOP: 95.06
3e50_C50 Protransforming growth factor alpha; IDE, TGF-alph 94.98
2kl7_A71 Fibulin-4; secreted, calcium, disease mutation, di 94.97
3cfw_A164 L-selectin; EGF, cell adhesion, EGF-like domain, g 94.81
1g1t_A157 E-selectin; EGF, adhesion molecule, SLEX, immune s 94.6
2i9a_A145 Urokinase-type plasminogen activator; growth facto 94.27
1kli_L69 Factor VIIA; extrinsic coagulation pathway, serine 93.84
3e50_C50 Protransforming growth factor alpha; IDE, TGF-alph 93.8
1iox_A50 Betacellulin; EGF-like fold, hormone/growth factor 93.67
2rnl_A50 Amphiregulin; AR, colorectum cell-derived growth f 93.66
1g1t_A157 E-selectin; EGF, adhesion molecule, SLEX, immune s 93.52
1kig_L51 Factor XA; glycoprotein, serine protease, plasma, 93.26
1xdt_R79 Hbegf, heparin-binding epidermal growth factor; co 93.13
3asi_A410 Neurexin-1-alpha; beta-sandwich, cell adhesion, sy 93.04
2bz6_L53 Blood coagulation factor VIIA; serine protease, en 92.82
1kig_L51 Factor XA; glycoprotein, serine protease, plasma, 92.62
1xdt_R79 Hbegf, heparin-binding epidermal growth factor; co 92.22
2bz6_L53 Blood coagulation factor VIIA; serine protease, en 91.92
1iox_A50 Betacellulin; EGF-like fold, hormone/growth factor 91.9
2ygo_A188 WIF-1, WNT inhibitory factor 1; signaling protein, 91.13
2i9a_A145 Urokinase-type plasminogen activator; growth facto 90.76
2rnl_A50 Amphiregulin; AR, colorectum cell-derived growth f 90.75
1szb_A170 Mannose binding lectin-associated serine protease- 90.58
3asi_A 410 Neurexin-1-alpha; beta-sandwich, cell adhesion, sy 90.42
1gbs_A185 Australian black SWAN egg white lysozyme; hydrolas 90.39
2ygo_A188 WIF-1, WNT inhibitory factor 1; signaling protein, 89.6
1ob1_C99 Major merozoite surface protein; immune system, im 89.07
3qcw_A1245 Neurexin-1-alpha; synaptic adhesion molecule, cell 88.96
3gxr_A187 Goose-type lysozyme 1; atlantic COD, FISH lysozyme 87.6
3qcw_A 1245 Neurexin-1-alpha; synaptic adhesion molecule, cell 87.58
3t21_A206 Endo-type membrane-bound lytic murein transglycos; 87.19
2e26_A 725 Reelin, reeler protein; signaling protein; HET: NA 86.82
2wph_E59 Coagulation factor IXA light chain; serine proteas 86.79
1szb_A170 Mannose binding lectin-associated serine protease- 86.11
1n1i_A105 Merozoite surface protein-1; MSP1, malaria, surfac 84.19
4aqt_A375 Laminin subunit gamma-1; cell adhesion; HET: NAG B 83.22
2wph_E59 Coagulation factor IXA light chain; serine proteas 82.81
1nzi_A159 Complement C1S component; calcium, innate immunity 80.85
>1hml_A Alpha-lactalbumin; calcium-binding protein; 1.70A {Homo sapiens} SCOP: d.2.1.2 Back     alignment and structure
Probab=100.00  E-value=2.3e-47  Score=362.63  Aligned_cols=119  Identities=32%  Similarity=0.640  Sum_probs=110.7

Q ss_pred             ccceeecchHHHHHHHHhcCCCCCCcccceEeeccccCCCcccccCCCCCCCceeeeeeeccccccCCCCCC--cccccc
Q psy9686         276 IEGKRFGACELAKFLVRQRGIARRDVPTWVCIATKESNRNSNARSPKNGNGSRDHGIFQINDKYWCTASGPA--GKECHA  353 (769)
Q Consensus       276 ~~ak~~~rCela~~l~~~~g~~~~~l~~wvCla~~eS~~~t~a~~~~~~~gs~~yGifQIn~~~WC~~~~~~--~~~C~~  353 (769)
                      ++||+|+||||||+|+..+||++++|++|||||++||+|||+|+++ | |||+|||||||||+|||++++.+  +|.|+|
T Consensus        17 ~~ak~~~rCeLar~L~~~~g~~~~~l~~WvCiA~~ES~~nt~a~n~-n-dgS~dyGLFQINs~~WC~~~~~~~~~n~C~i   94 (142)
T 1hml_A           17 ILAKQFTKCELSQLLKDIDGYGGIALPELICTMFHTSGYDTQAIVE-N-NESTEYGLFQISNKLWCKSSQVPQSRNICDI   94 (142)
T ss_dssp             ---CBCCHHHHHHHTGGGTTGGGCCHHHHHHHHHHHHTTBTTCEEE-C-SSCEEETTTTEETTTTSBCTTCTTCCCTTCS
T ss_pred             hccceechhHHHHHHHhccCCChhHHHHHHHHHHHhcCCCccCeeC-C-CCCcceeeeeechhhhcCCCCCCcccccCCC
Confidence            6899999999999999767999999999999999999999999997 6 99999999999999999988653  699999


Q ss_pred             ccccccCCChhHHHHHHHHHHhcccccccCcccccccCc-cccCCCCCcccc
Q psy9686         354 KCSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTYH-YCNTNSKVSTYD  404 (769)
Q Consensus       354 ~C~~ll~~di~~~i~Cak~i~~~~~~~~~~G~~aW~~w~-~C~g~~~l~~~~  404 (769)
                      +|++||||||+|||+|||+|+++      +||+||++|+ ||+|  ||++|.
T Consensus        95 ~C~dLl~ddI~~~i~CAk~I~~~------~G~~aW~~w~~~C~g--~l~~w~  138 (142)
T 1hml_A           95 SCDKFLDDDITDDIMCAKKILDI------KGIDYWLAHKALCTE--KLEQWL  138 (142)
T ss_dssp             BGGGGSSSCCHHHHHHHHHHHHH------TCGGGSTHHHHHSSS--SCGGGC
T ss_pred             CHHHHcCccHHHHHHHHHHHHHh------cCcchhHHHHHhCCC--CCcccc
Confidence            99999999999999999999998      6999999999 9999  799996



>1iiz_A Lysozyme; hydrolase; 2.40A {Antheraea mylitta} SCOP: d.2.1.2 PDB: 1gd6_A Back     alignment and structure
>1b9o_A Protein (alpha-lactalbumin); calcium-binding protein, high resolution; 1.15A {Homo sapiens} SCOP: d.2.1.2 PDB: 1a4v_A 1alc_A 1hmk_A 1hfy_A 1f6r_A 1f6s_A 2g4n_A 1fkq_A 1fkv_A 1hfz_A 1hfx_A Back     alignment and structure
>1yro_A Alpha-lactalbumin; Arg228Lys mutation, UDP-GAL complex, transferase activator/transferase complex; HET: GDU UDP MES PG4; 1.90A {Mus musculus} SCOP: d.2.1.2 PDB: 1nhe_A* 1nkh_A* 1nmm_A* 1nqi_A* 1nwg_A* 1o23_A* 1oqm_A* 1pzy_A* 1nf5_A* 2fyc_A* 2fyd_A* Back     alignment and structure
>1qqy_A Lysozyme C; APO-type protein, calcium binding lysozyme, enzyme, hydrolase; 1.85A {Canis lupus familiaris} SCOP: d.2.1.2 PDB: 1el1_A 1i56_A 2cwi_A 2z2e_A 2eql_A Back     alignment and structure
>2goi_A Sperm lysozyme-like protein 1; mouse SLLP1, MSLLP1, sperm C-type lysozyme-like protein 1, acrosomal sperm protein, sperm-egg binding, fertilization; 2.30A {Mus musculus} Back     alignment and structure
>2gv0_A Lysozyme C; hydrolase; 1.90A {Pelodiscus sinensis} Back     alignment and structure
>2nwd_X Lysozyme C; native chemical ligation, chemical protein synthesis, convergent synthesis, hydrolase; 1.04A {Synthetic} SCOP: d.2.1.2 PDB: 1iwu_A 1iwv_A 1iww_A 1iwx_A 1iwy_A 1iwz_A 1iy3_A 1iy4_A 1iwt_A 1jwr_A 1lz1_A 1lzr_A* 1lzs_A* 1op9_B 1re2_A* 1rem_A* 1rex_A 1rey_A* 1rez_A* 1jsf_A ... Back     alignment and structure
>2z2f_A Lysozyme C-2; stomach lysozyme, 1,4-beta-N-acetylmuramidase C, bacteriolytic enzyme, hydrolase; 1.50A {Bos taurus} Back     alignment and structure
>2fbd_A Lysozyme 1; digestive lysozime, hydrolase; HET: PEG; 1.90A {Musca domestica} PDB: 2h5z_A* 3cb7_A Back     alignment and structure
>3b72_A Lysozyme C; hen egg-white lysozyme, protein-SDS complex, MPD, allergen, antimicrobial, bacteriolytic enzyme glycosidase, hydrolase; 1.50A {Gallus gallus} SCOP: d.2.1.2 PDB: 3b6l_A 1lsy_A 1lsz_A* Back     alignment and structure
>1lsg_A Hen egg white lysozyme; fibrinogen, hybrid protein; 2.40A {Gallus gallus} SCOP: d.2.1.2 Back     alignment and structure
>2vb1_A Lysozyme C; antimicrobial, triclinic HEWL, atomic resolution, allergen, hydrolase, glycosidase, bacteriolytic enzyme; HET: EDO; 0.65A {Gallus gallus} SCOP: d.2.1.2 PDB: 194l_A 1aki_A 1azf_A 1b0d_A* 1b2k_A 1bgi_A 1bhz_A 1bvk_C 1bvx_A 1bwh_A 1bwi_A 1bwj_A 1c08_C 1c10_A 1dpw_A 1dpx_A 1dqj_C 1e8l_A 1f0w_A 1f10_A ... Back     alignment and structure
>1jug_A Lysozyme; calcium-binding; 1.90A {Tachyglossus aculeatus} SCOP: d.2.1.2 Back     alignment and structure
>1lmq_A Lysozyme; hydrolase (O-glycosyl); HET: NAG NDG; 1.60A {Oncorhynchus mykiss} SCOP: d.2.1.2 PDB: 1bb7_A* 1lmc_A* 1bb6_A 1lmo_A* 1lmp_A* 1lmn_A* Back     alignment and structure
>1iiz_A Lysozyme; hydrolase; 2.40A {Antheraea mylitta} SCOP: d.2.1.2 PDB: 1gd6_A Back     alignment and structure
>1qqy_A Lysozyme C; APO-type protein, calcium binding lysozyme, enzyme, hydrolase; 1.85A {Canis lupus familiaris} SCOP: d.2.1.2 PDB: 1el1_A 1i56_A 2cwi_A 2z2e_A 2eql_A Back     alignment and structure
>2goi_A Sperm lysozyme-like protein 1; mouse SLLP1, MSLLP1, sperm C-type lysozyme-like protein 1, acrosomal sperm protein, sperm-egg binding, fertilization; 2.30A {Mus musculus} Back     alignment and structure
>2gv0_A Lysozyme C; hydrolase; 1.90A {Pelodiscus sinensis} Back     alignment and structure
>2nwd_X Lysozyme C; native chemical ligation, chemical protein synthesis, convergent synthesis, hydrolase; 1.04A {Synthetic} SCOP: d.2.1.2 PDB: 1iwu_A 1iwv_A 1iww_A 1iwx_A 1iwy_A 1iwz_A 1iy3_A 1iy4_A 1iwt_A 1jwr_A 1lz1_A 1lzr_A* 1lzs_A* 1op9_B 1re2_A* 1rem_A* 1rex_A 1rey_A* 1rez_A* 1jsf_A ... Back     alignment and structure
>1b9o_A Protein (alpha-lactalbumin); calcium-binding protein, high resolution; 1.15A {Homo sapiens} SCOP: d.2.1.2 PDB: 1a4v_A 1alc_A 1hmk_A 1hfy_A 1f6r_A 1f6s_A 2g4n_A 1fkq_A 1fkv_A 1hfz_A 1hfx_A Back     alignment and structure
>2vb1_A Lysozyme C; antimicrobial, triclinic HEWL, atomic resolution, allergen, hydrolase, glycosidase, bacteriolytic enzyme; HET: EDO; 0.65A {Gallus gallus} SCOP: d.2.1.2 PDB: 194l_A 1aki_A 1azf_A 1b0d_A* 1b2k_A 1bgi_A 1bhz_A 1bvk_C 1bvx_A 1bwh_A 1bwi_A 1bwj_A 1c08_C 1c10_A 1dpw_A 1dpx_A 1dqj_C 1e8l_A 1f0w_A 1f10_A ... Back     alignment and structure
>1yro_A Alpha-lactalbumin; Arg228Lys mutation, UDP-GAL complex, transferase activator/transferase complex; HET: GDU UDP MES PG4; 1.90A {Mus musculus} SCOP: d.2.1.2 PDB: 1nhe_A* 1nkh_A* 1nmm_A* 1nqi_A* 1nwg_A* 1o23_A* 1oqm_A* 1pzy_A* 1nf5_A* 2fyc_A* 2fyd_A* Back     alignment and structure
>2z2f_A Lysozyme C-2; stomach lysozyme, 1,4-beta-N-acetylmuramidase C, bacteriolytic enzyme, hydrolase; 1.50A {Bos taurus} Back     alignment and structure
>1hml_A Alpha-lactalbumin; calcium-binding protein; 1.70A {Homo sapiens} SCOP: d.2.1.2 Back     alignment and structure
>1lsg_A Hen egg white lysozyme; fibrinogen, hybrid protein; 2.40A {Gallus gallus} SCOP: d.2.1.2 Back     alignment and structure
>2fbd_A Lysozyme 1; digestive lysozime, hydrolase; HET: PEG; 1.90A {Musca domestica} PDB: 2h5z_A* 3cb7_A Back     alignment and structure
>3b72_A Lysozyme C; hen egg-white lysozyme, protein-SDS complex, MPD, allergen, antimicrobial, bacteriolytic enzyme glycosidase, hydrolase; 1.50A {Gallus gallus} SCOP: d.2.1.2 PDB: 3b6l_A 1lsy_A 1lsz_A* Back     alignment and structure
>1lmq_A Lysozyme; hydrolase (O-glycosyl); HET: NAG NDG; 1.60A {Oncorhynchus mykiss} SCOP: d.2.1.2 PDB: 1bb7_A* 1lmc_A* 1bb6_A 1lmo_A* 1lmp_A* 1lmn_A* Back     alignment and structure
>1jug_A Lysozyme; calcium-binding; 1.90A {Tachyglossus aculeatus} SCOP: d.2.1.2 Back     alignment and structure
>1z1y_A Ookinete surface protein PVS25; four EGF-like domains, cell adhesion; HET: MLY; 2.00A {Plasmodium vivax} PDB: 1z27_A 1z3g_A Back     alignment and structure
>2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* Back     alignment and structure
>2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* Back     alignment and structure
>4fbr_A Lectin, myxobacterial hemagglutinin; beta-barrel, HIV-inactivating, carbohydrate binding protein; 1.60A {Myxococcus xanthus} PDB: 4fbv_A* Back     alignment and structure
>4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} Back     alignment and structure
>1z1y_A Ookinete surface protein PVS25; four EGF-like domains, cell adhesion; HET: MLY; 2.00A {Plasmodium vivax} PDB: 1z27_A 1z3g_A Back     alignment and structure
>2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} Back     alignment and structure
>1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* Back     alignment and structure
>4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} Back     alignment and structure
>3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 4g1e_B* 3ije_B* 4g1m_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B* Back     alignment and structure
>1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A Back     alignment and structure
>1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* Back     alignment and structure
>4fbr_A Lectin, myxobacterial hemagglutinin; beta-barrel, HIV-inactivating, carbohydrate binding protein; 1.60A {Myxococcus xanthus} PDB: 4fbv_A* Back     alignment and structure
>2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A Back     alignment and structure
>2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A Back     alignment and structure
>2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} Back     alignment and structure
>2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A Back     alignment and structure
>2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A Back     alignment and structure
>1dx5_I Thrombomodulin; serine proteinase, EGF-like domains, anticoagulant complex, antifibrinolytic complex, hydrolase-hydrolase inhibitor COM; HET: AR7 NDG; 2.30A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 3gis_X 1dqb_A* 1zaq_A 1adx_A 2adx_A Back     alignment and structure
>1tpg_A T-plasminogen activator F1-G; plasminogen activation; NMR {Homo sapiens} SCOP: g.3.11.1 g.27.1.1 PDB: 1tpm_A 1tpn_A Back     alignment and structure
>1dx5_I Thrombomodulin; serine proteinase, EGF-like domains, anticoagulant complex, antifibrinolytic complex, hydrolase-hydrolase inhibitor COM; HET: AR7 NDG; 2.30A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 3gis_X 1dqb_A* 1zaq_A 1adx_A 2adx_A Back     alignment and structure
>2w86_A Fibrillin-1, fibrillin1; phosphoprotein, EGF-like domain, disease mutation, craniosynostosis, extracellular matrix, fibrillin calcium cbegf hybrid; 1.80A {Homo sapiens} Back     alignment and structure
>3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Back     alignment and structure
>1tpg_A T-plasminogen activator F1-G; plasminogen activation; NMR {Homo sapiens} SCOP: g.3.11.1 g.27.1.1 PDB: 1tpm_A 1tpn_A Back     alignment and structure
>3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 4g1e_B* 3ije_B* 4g1m_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B* Back     alignment and structure
>1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A Back     alignment and structure
>1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A Back     alignment and structure
>1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* Back     alignment and structure
>1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A Back     alignment and structure
>2w86_A Fibrillin-1, fibrillin1; phosphoprotein, EGF-like domain, disease mutation, craniosynostosis, extracellular matrix, fibrillin calcium cbegf hybrid; 1.80A {Homo sapiens} Back     alignment and structure
>1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} Back     alignment and structure
>2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* Back     alignment and structure
>2c4f_L Coagulation factor VII precursor; blood coagulation, serine protease, EGF, EGF-like domain, GLA, receptor enzyme, glycoprotein, hydrolase, protease; HET: CGU GLC FUC NAG GIL; 1.72A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.32.1.1 PDB: 1w2k_L* 1w0y_L* 1z6j_L* 2b8o_L* 2aer_L* 2ec9_L* 2fir_L* 2a2q_L* 1fak_L* 1o5d_L* 1wqv_L* 1wss_L* 1wtg_L* 1wun_L* 1wv7_L* 1dan_L* 2aei_L* 2b7d_L* 2f9b_L* 2flb_L* ... Back     alignment and structure
>2c4f_L Coagulation factor VII precursor; blood coagulation, serine protease, EGF, EGF-like domain, GLA, receptor enzyme, glycoprotein, hydrolase, protease; HET: CGU GLC FUC NAG GIL; 1.72A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.32.1.1 PDB: 1w2k_L* 1w0y_L* 1z6j_L* 2b8o_L* 2aer_L* 2ec9_L* 2fir_L* 2a2q_L* 1fak_L* 1o5d_L* 1wqv_L* 1wss_L* 1wtg_L* 1wun_L* 1wv7_L* 1dan_L* 2aei_L* 2b7d_L* 2f9b_L* 2flb_L* ... Back     alignment and structure
>1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* Back     alignment and structure
>2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* Back     alignment and structure
>1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 Back     alignment and structure
>1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 Back     alignment and structure
>1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* Back     alignment and structure
>1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* Back     alignment and structure
>2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ... Back     alignment and structure
>4aqs_A Laminin subunit beta-1; cell adhesion; HET: NAG BMA MAN FUL; 3.11A {Mus musculus} Back     alignment and structure
>3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* Back     alignment and structure
>1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} Back     alignment and structure
>1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* Back     alignment and structure
>1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* Back     alignment and structure
>3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens} Back     alignment and structure
>2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A Back     alignment and structure
>2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ... Back     alignment and structure
>2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A Back     alignment and structure
>3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens} Back     alignment and structure
>3u7u_G Neuregulin 1; signaling protein, transferase-transferase regulator complex glycosylation; HET: NAG; 3.03A {Homo sapiens} Back     alignment and structure
>1n7d_A LDL receptor, low-density lipoprotein receptor; familial hypercholesterolemia, cholestero metabolism, lipid transport; HET: NAG BMA MAN KEG; 3.70A {Homo sapiens} SCOP: b.68.5.1 g.3.11.1 g.3.11.1 g.3.11.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 PDB: 2lgp_A 1xfe_A 1f5y_A 1ldl_A 1ldr_A 1d2j_A 1f8z_A Back     alignment and structure
>2p28_B Integrin beta-2; hybrid domain, PSI domain, I-EGF DOM cell adhesion; HET: NAG; 2.20A {Homo sapiens} PDB: 1l3y_A Back     alignment and structure
>3m0c_C LDL receptor, low-density lipoprotein receptor; protein complex, beta propeller, cholesterol clearance, PCSK autocatalytic cleavage; 7.01A {Homo sapiens} Back     alignment and structure
>1klo_A Laminin; glycoprotein; 2.10A {Mus musculus} SCOP: g.3.11.2 g.3.11.2 g.3.11.2 PDB: 1npe_B 1tle_A Back     alignment and structure
>1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A Back     alignment and structure
>1n7d_A LDL receptor, low-density lipoprotein receptor; familial hypercholesterolemia, cholestero metabolism, lipid transport; HET: NAG BMA MAN KEG; 3.70A {Homo sapiens} SCOP: b.68.5.1 g.3.11.1 g.3.11.1 g.3.11.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 PDB: 2lgp_A 1xfe_A 1f5y_A 1ldl_A 1ldr_A 1d2j_A 1f8z_A Back     alignment and structure
>3p5b_L Low density lipoprotein receptor variant; B-propellor, convertase, hydrolase-lipid binding P complex; 3.30A {Homo sapiens} PDB: 3p5c_L Back     alignment and structure
>3u7u_G Neuregulin 1; signaling protein, transferase-transferase regulator complex glycosylation; HET: NAG; 3.03A {Homo sapiens} Back     alignment and structure
>3p5b_L Low density lipoprotein receptor variant; B-propellor, convertase, hydrolase-lipid binding P complex; 3.30A {Homo sapiens} PDB: 3p5c_L Back     alignment and structure
>3v65_B Low-density lipoprotein receptor-related protein; laminin-G, beta-propeller, protein binding; 3.30A {Rattus norvegicus} Back     alignment and structure
>3m0c_C LDL receptor, low-density lipoprotein receptor; protein complex, beta propeller, cholesterol clearance, PCSK autocatalytic cleavage; 7.01A {Homo sapiens} Back     alignment and structure
>2wg3_C Hedgehog-interacting protein; lipoprotein, development, membrane, secreted, protease, PALM hydrolase, developmental protein, autocatalytic cleavage; HET: NAG; 2.60A {Homo sapiens} PDB: 2wg4_B 2wfx_B 2wft_A 3ho3_A 3ho4_A 3ho5_A Back     alignment and structure
>2k2s_B Micronemal protein 6; microneme protein complex, cell adhesion, cytoplasmic vesicl lectin, virulence, EGF-like domain, membrane; NMR {Toxoplasma gondii} PDB: 2k2t_A Back     alignment and structure
>2p28_B Integrin beta-2; hybrid domain, PSI domain, I-EGF DOM cell adhesion; HET: NAG; 2.20A {Homo sapiens} PDB: 1l3y_A Back     alignment and structure
>3v65_B Low-density lipoprotein receptor-related protein; laminin-G, beta-propeller, protein binding; 3.30A {Rattus norvegicus} Back     alignment and structure
>1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A Back     alignment and structure
>1egf_A Epidermal growth factor; NMR {Mus musculus} SCOP: g.3.11.1 PDB: 1epg_A 1eph_A 1epi_A 1epj_A 3egf_A 1gk5_A Back     alignment and structure
>1egf_A Epidermal growth factor; NMR {Mus musculus} SCOP: g.3.11.1 PDB: 1epg_A 1eph_A 1epi_A 1epj_A 3egf_A 1gk5_A Back     alignment and structure
>1a3p_A Epidermal growth factor; disulfide connectivities, EGF-like domain, repeat; HET: ABA; NMR {Mus musculus} SCOP: g.3.11.1 Back     alignment and structure
>1hae_A Heregulin-alpha; growth factor; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1haf_A 1hre_A 1hrf_A Back     alignment and structure
>1hae_A Heregulin-alpha; growth factor; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1haf_A 1hre_A 1hrf_A Back     alignment and structure
>1k36_A Epiregulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1k37_A Back     alignment and structure
>1a3p_A Epidermal growth factor; disulfide connectivities, EGF-like domain, repeat; HET: ABA; NMR {Mus musculus} SCOP: g.3.11.1 Back     alignment and structure
>1k36_A Epiregulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1k37_A Back     alignment and structure
>2k2s_B Micronemal protein 6; microneme protein complex, cell adhesion, cytoplasmic vesicl lectin, virulence, EGF-like domain, membrane; NMR {Toxoplasma gondii} PDB: 2k2t_A Back     alignment and structure
>3ca7_A Protein spitz; argos, EGF, developmental protein, differentiation, EGF-like domain, endoplasmic reticulum, glycoprotein, golgi apparatus; 1.50A {Drosophila melanogaster} PDB: 3c9a_C 3ltg_D Back     alignment and structure
>2wg3_C Hedgehog-interacting protein; lipoprotein, development, membrane, secreted, protease, PALM hydrolase, developmental protein, autocatalytic cleavage; HET: NAG; 2.60A {Homo sapiens} PDB: 2wg4_B 2wfx_B 2wft_A 3ho3_A 3ho4_A 3ho5_A Back     alignment and structure
>4aqs_A Laminin subunit beta-1; cell adhesion; HET: NAG BMA MAN FUL; 3.11A {Mus musculus} Back     alignment and structure
>3zyj_B Netrin-G1; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>3zyj_B Netrin-G1; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>1g1s_A P-selectin; selectin, lectin, EGF, sulphated, SLEX, immune system, membr protein; HET: TYS SIA GAL NAG FUC NGA; 1.90A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1g1r_A* 1g1q_A* 1fsb_A Back     alignment and structure
>1nql_B Epidermal growth factor; cell surface receptor, tyrosine kinase, glycoprotein, endoso growth factor, auto-inhibition; HET: NAG BMA; 2.80A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ivo_C* 2kv4_A 1jl9_A 1p9j_A 3njp_C* Back     alignment and structure
>1nql_B Epidermal growth factor; cell surface receptor, tyrosine kinase, glycoprotein, endoso growth factor, auto-inhibition; HET: NAG BMA; 2.80A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ivo_C* 2kv4_A 1jl9_A 1p9j_A 3njp_C* Back     alignment and structure
>1g1s_A P-selectin; selectin, lectin, EGF, sulphated, SLEX, immune system, membr protein; HET: TYS SIA GAL NAG FUC NGA; 1.90A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1g1r_A* 1g1q_A* 1fsb_A Back     alignment and structure
>3ca7_A Protein spitz; argos, EGF, developmental protein, differentiation, EGF-like domain, endoplasmic reticulum, glycoprotein, golgi apparatus; 1.50A {Drosophila melanogaster} PDB: 3c9a_C 3ltg_D Back     alignment and structure
>2fd6_A Urokinase-type plasminogen activator; UPAR, ATF, ATN-615 antibody, FAB, ternary complex, immune SY hydrolase; HET: PGE NAG FUC NDG PG4; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 3bt2_A* 3bt1_A* 3u73_A* 1urk_A* 3laq_A* 1kdu_A Back     alignment and structure
>3ltf_D Protein spitz; receptor-ligand complex ectodomain cysteine rich domain EGF ATP-binding, kinase, nucleotide-binding, receptor; HET: NAG MAN; 3.20A {Drosophila melanogaster} Back     alignment and structure
>1gl4_A Nidogen-1, entactin; immunoglobulin-like domain, extracellular matrix; HET: EPE; 2.0A {Mus musculus} SCOP: d.22.1.2 g.3.11.5 PDB: 1h4u_A Back     alignment and structure
>1q4g_A Prostaglandin G/H synthase 1; cyclooxygenase, non-steroidal anti-inflammatory drug, peroxi prostaglandin synthase, EGF-like domain; HET: BOG NAG NDG BMA MAN BFL HEM; 2.00A {Ovis aries} SCOP: a.93.1.2 g.3.11.1 PDB: 1diy_A* 2ayl_A* 3kk6_A* 3n8v_A* 3n8w_A* 3n8x_A* 3n8y_A* 3n8z_A* 2oyu_P* 2oye_P* 1eqg_A* 1cqe_A* 1eqh_A* 1igz_A* 1igx_A* 1fe2_A* 1pge_A* 1pgf_A* 1pgg_A* 3n8w_B* ... Back     alignment and structure
>3ltf_D Protein spitz; receptor-ligand complex ectodomain cysteine rich domain EGF ATP-binding, kinase, nucleotide-binding, receptor; HET: NAG MAN; 3.20A {Drosophila melanogaster} Back     alignment and structure
>1ob1_C Major merozoite surface protein; immune system, immunoglobulin/complex, immunoglobulin, antib fragment, MSP1-19, EGF-like domain; 2.90A {Plasmodium falciparum} SCOP: g.3.11.4 g.3.11.4 PDB: 1cej_A 2flg_A Back     alignment and structure
>3nt1_A Prostaglandin-endoperoxide synthase 2; prostaglandin H2 synthase, cyclooxygenase-2, naproxen, oxido; HET: NAG BOG NPS HEM; 1.73A {Mus musculus} PDB: 3ln1_A* 3mqe_A* 3ln0_A* 3ntb_A* 3q7d_A* 4fm5_A* 1pxx_A* 3pgh_A* 1cx2_A* 4cox_A* 5cox_A* 6cox_A* 3qh0_A* 3qmo_A* 4e1g_A* 3olu_A* 3olt_A* 3hs5_A* 3hs6_A* 3hs7_A* ... Back     alignment and structure
>2jkh_L Factor X light chain; plasma, calcium, zymogen, secreted, protease, hydrolase, polymorphism, glycoprotein, gamma-carboxyglutamic acid; HET: BI7; 1.25A {Homo sapiens} PDB: 2bok_L* 2vvc_K* 2vvu_L* 2vvv_L* 2vwl_L* 2vwm_K* 2vwn_L* 2vwo_L* 2xbv_L* 2xbw_L* 2xbx_L* 2xby_L* 2xc0_L* 2xc4_L* 2xc5_L* 2gd4_L* 3kl6_B* 2y5f_L* 2y5g_L* 2y5h_L* ... Back     alignment and structure
>1apq_A Complement protease C1R; EGF, calcium binding, serine protease; NMR {Homo sapiens} SCOP: g.3.11.1 Back     alignment and structure
>1q4g_A Prostaglandin G/H synthase 1; cyclooxygenase, non-steroidal anti-inflammatory drug, peroxi prostaglandin synthase, EGF-like domain; HET: BOG NAG NDG BMA MAN BFL HEM; 2.00A {Ovis aries} SCOP: a.93.1.2 g.3.11.1 PDB: 1diy_A* 2ayl_A* 3kk6_A* 3n8v_A* 3n8w_A* 3n8x_A* 3n8y_A* 3n8z_A* 2oyu_P* 2oye_P* 1eqg_A* 1cqe_A* 1eqh_A* 1igz_A* 1igx_A* 1fe2_A* 1pge_A* 1pgf_A* 1pgg_A* 3n8w_B* ... Back     alignment and structure
>1gl4_A Nidogen-1, entactin; immunoglobulin-like domain, extracellular matrix; HET: EPE; 2.0A {Mus musculus} SCOP: d.22.1.2 g.3.11.5 PDB: 1h4u_A Back     alignment and structure
>1n1i_A Merozoite surface protein-1; MSP1, malaria, surface antigen, glycoprotein, EGF domain, cell adhesion; HET: HIS; 2.40A {Plasmodium knowlesi strain H} SCOP: g.3.11.4 g.3.11.4 Back     alignment and structure
>2fd6_A Urokinase-type plasminogen activator; UPAR, ATF, ATN-615 antibody, FAB, ternary complex, immune SY hydrolase; HET: PGE NAG FUC NDG PG4; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 3bt2_A* 3bt1_A* 3u73_A* 1urk_A* 3laq_A* 1kdu_A Back     alignment and structure
>1kli_L Factor VIIA; extrinsic coagulation pathway, serine protease activation, R drug design, substrate-assisted catalysis, hydrolase; 1.69A {Homo sapiens} SCOP: g.3.11.1 PDB: 1klj_L 1jbu_L 1ygc_L* Back     alignment and structure
>1apq_A Complement protease C1R; EGF, calcium binding, serine protease; NMR {Homo sapiens} SCOP: g.3.11.1 Back     alignment and structure
>2kl7_A Fibulin-4; secreted, calcium, disease mutation, disulfide bond, EGF- like domain, glycoprotein, polymorphism, structural genomics, PSI-2; NMR {Homo sapiens} Back     alignment and structure
>3nt1_A Prostaglandin-endoperoxide synthase 2; prostaglandin H2 synthase, cyclooxygenase-2, naproxen, oxido; HET: NAG BOG NPS HEM; 1.73A {Mus musculus} PDB: 3ln1_A* 3mqe_A* 3ln0_A* 3ntb_A* 3q7d_A* 4fm5_A* 1pxx_A* 3pgh_A* 1cx2_A* 4cox_A* 5cox_A* 6cox_A* 3qh0_A* 3qmo_A* 4e1g_A* 3olu_A* 3olt_A* 3hs5_A* 3hs6_A* 3hs7_A* ... Back     alignment and structure
>2jkh_L Factor X light chain; plasma, calcium, zymogen, secreted, protease, hydrolase, polymorphism, glycoprotein, gamma-carboxyglutamic acid; HET: BI7; 1.25A {Homo sapiens} PDB: 2bok_L* 2vvc_K* 2vvu_L* 2vvv_L* 2vwl_L* 2vwm_K* 2vwn_L* 2vwo_L* 2xbv_L* 2xbw_L* 2xbx_L* 2xby_L* 2xc0_L* 2xc4_L* 2xc5_L* 2gd4_L* 3kl6_B* 2y5f_L* 2y5g_L* 2y5h_L* ... Back     alignment and structure
>1klo_A Laminin; glycoprotein; 2.10A {Mus musculus} SCOP: g.3.11.2 g.3.11.2 g.3.11.2 PDB: 1npe_B 1tle_A Back     alignment and structure
>3e50_C Protransforming growth factor alpha; IDE, TGF-alpha, cytoplasm, hydrolase, metal-binding, metalloprotease, polymorphism, protease, zinc; 2.30A {Homo sapiens} SCOP: g.3.11.1 PDB: 1yuf_A 1yug_A 2tgf_A 1mox_C 3tgf_A 4tgf_A Back     alignment and structure
>2kl7_A Fibulin-4; secreted, calcium, disease mutation, disulfide bond, EGF- like domain, glycoprotein, polymorphism, structural genomics, PSI-2; NMR {Homo sapiens} Back     alignment and structure
>1g1t_A E-selectin; EGF, adhesion molecule, SLEX, immune system, membrane protein; HET: SIA GAL MAG FUC; 1.50A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1esl_A Back     alignment and structure
>2i9a_A Urokinase-type plasminogen activator; growth factor-like domain, kringle domain, hydrolase; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 2i9b_A* Back     alignment and structure
>1kli_L Factor VIIA; extrinsic coagulation pathway, serine protease activation, R drug design, substrate-assisted catalysis, hydrolase; 1.69A {Homo sapiens} SCOP: g.3.11.1 PDB: 1klj_L 1jbu_L 1ygc_L* Back     alignment and structure
>3e50_C Protransforming growth factor alpha; IDE, TGF-alpha, cytoplasm, hydrolase, metal-binding, metalloprotease, polymorphism, protease, zinc; 2.30A {Homo sapiens} SCOP: g.3.11.1 PDB: 1yuf_A 1yug_A 2tgf_A 1mox_C 3tgf_A 4tgf_A Back     alignment and structure
>1iox_A Betacellulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1ip0_A Back     alignment and structure
>2rnl_A Amphiregulin; AR, colorectum cell-derived growth factor, EGF-like domain, CRDGF, cytokine, glycoprotein, membrane, polymorphism, transmembrane; NMR {Homo sapiens} Back     alignment and structure
>1g1t_A E-selectin; EGF, adhesion molecule, SLEX, immune system, membrane protein; HET: SIA GAL MAG FUC; 1.50A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1esl_A Back     alignment and structure
>1kig_L Factor XA; glycoprotein, serine protease, plasma, blood coagulation, complex (protease/inhibitor); 3.00A {Bos taurus} SCOP: g.3.11.1 Back     alignment and structure
>1xdt_R Hbegf, heparin-binding epidermal growth factor; complex (toxin-growth factor), diphtheria toxin, receptor, H binding epidermal growth factor; 2.65A {Homo sapiens} SCOP: g.3.11.1 Back     alignment and structure
>3asi_A Neurexin-1-alpha; beta-sandwich, cell adhesion, synapse maturation, neuroligin glycosylation, membrane; HET: NAG; 2.30A {Bos taurus} Back     alignment and structure
>2bz6_L Blood coagulation factor VIIA; serine protease, enzyme complex, hydrolase; HET: 346; 1.6A {Homo sapiens} SCOP: g.3.11.1 PDB: 1w8b_L* 1w7x_L* 1cvw_L* Back     alignment and structure
>1kig_L Factor XA; glycoprotein, serine protease, plasma, blood coagulation, complex (protease/inhibitor); 3.00A {Bos taurus} SCOP: g.3.11.1 Back     alignment and structure
>1xdt_R Hbegf, heparin-binding epidermal growth factor; complex (toxin-growth factor), diphtheria toxin, receptor, H binding epidermal growth factor; 2.65A {Homo sapiens} SCOP: g.3.11.1 Back     alignment and structure
>2bz6_L Blood coagulation factor VIIA; serine protease, enzyme complex, hydrolase; HET: 346; 1.6A {Homo sapiens} SCOP: g.3.11.1 PDB: 1w8b_L* 1w7x_L* 1cvw_L* Back     alignment and structure
>1iox_A Betacellulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1ip0_A Back     alignment and structure
>2ygo_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: MLY PCF NAG; 1.85A {Homo sapiens} PDB: 2ygp_A* Back     alignment and structure
>2i9a_A Urokinase-type plasminogen activator; growth factor-like domain, kringle domain, hydrolase; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 2i9b_A* Back     alignment and structure
>2rnl_A Amphiregulin; AR, colorectum cell-derived growth factor, EGF-like domain, CRDGF, cytokine, glycoprotein, membrane, polymorphism, transmembrane; NMR {Homo sapiens} Back     alignment and structure
>1szb_A Mannose binding lectin-associated serine protease-2 related protein, MAP19 (19KDA)...; calcium, complement, innate immunity, CUB, EGF; 2.50A {Homo sapiens} SCOP: b.23.1.1 g.3.11.1 Back     alignment and structure
>3asi_A Neurexin-1-alpha; beta-sandwich, cell adhesion, synapse maturation, neuroligin glycosylation, membrane; HET: NAG; 2.30A {Bos taurus} Back     alignment and structure
>1gbs_A Australian black SWAN egg white lysozyme; hydrolase (O-glycosyl); 1.50A {Cygnus atratus} SCOP: d.2.1.5 PDB: 1lsp_A* 153l_A 154l_A* Back     alignment and structure
>2ygo_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: MLY PCF NAG; 1.85A {Homo sapiens} PDB: 2ygp_A* Back     alignment and structure
>1ob1_C Major merozoite surface protein; immune system, immunoglobulin/complex, immunoglobulin, antib fragment, MSP1-19, EGF-like domain; 2.90A {Plasmodium falciparum} SCOP: g.3.11.4 g.3.11.4 PDB: 1cej_A 2flg_A Back     alignment and structure
>3qcw_A Neurexin-1-alpha; synaptic adhesion molecule, cell adhesion; HET: NAG; 2.65A {Bos taurus} PDB: 3r05_A* 3poy_A* Back     alignment and structure
>3gxr_A Goose-type lysozyme 1; atlantic COD, FISH lysozyme, active site residues, substrate sites, surface potential, muramidase activity; HET: NAG; 1.70A {Gadus morhua} SCOP: d.2.1.5 PDB: 3gxk_A* Back     alignment and structure
>3qcw_A Neurexin-1-alpha; synaptic adhesion molecule, cell adhesion; HET: NAG; 2.65A {Bos taurus} PDB: 3r05_A* 3poy_A* Back     alignment and structure
>2e26_A Reelin, reeler protein; signaling protein; HET: NAG BMA; 2.00A {Mus musculus} PDB: 3a7q_A* Back     alignment and structure
>2wph_E Coagulation factor IXA light chain; serine protease, zymogen, hydrolase, glycoprotein, hydroxylation, phosphoprotein, sulfation, hemostasis; HET: DPN 1PE; 1.50A {Homo sapiens} PDB: 2wpi_E* 2wpj_E* 2wpk_E* 2wpl_E* 2wpm_E 3kcg_L* 3lc3_B* 1rfn_B* 3lc5_B* Back     alignment and structure
>1szb_A Mannose binding lectin-associated serine protease-2 related protein, MAP19 (19KDA)...; calcium, complement, innate immunity, CUB, EGF; 2.50A {Homo sapiens} SCOP: b.23.1.1 g.3.11.1 Back     alignment and structure
>1n1i_A Merozoite surface protein-1; MSP1, malaria, surface antigen, glycoprotein, EGF domain, cell adhesion; HET: HIS; 2.40A {Plasmodium knowlesi strain H} SCOP: g.3.11.4 g.3.11.4 Back     alignment and structure
>4aqt_A Laminin subunit gamma-1; cell adhesion; HET: NAG BMA; 3.20A {Mus musculus} Back     alignment and structure
>2wph_E Coagulation factor IXA light chain; serine protease, zymogen, hydrolase, glycoprotein, hydroxylation, phosphoprotein, sulfation, hemostasis; HET: DPN 1PE; 1.50A {Homo sapiens} PDB: 2wpi_E* 2wpj_E* 2wpk_E* 2wpl_E* 2wpm_E 3kcg_L* 3lc3_B* 1rfn_B* 3lc5_B* Back     alignment and structure
>1nzi_A Complement C1S component; calcium, innate immunity, modular structure, CUB, EGF, hydrolase; 1.50A {Homo sapiens} SCOP: b.23.1.1 g.3.11.1 Back     alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 769
d1qqya_130 d.2.1.2 (A:) Lysozyme {Dog (Canis familiaris), mil 5e-33
d1qqya_130 d.2.1.2 (A:) Lysozyme {Dog (Canis familiaris), mil 3e-18
d1gd6a_119 d.2.1.2 (A:) Lysozyme {Silkworm (Bombyx mori) [Tax 3e-32
d1gd6a_119 d.2.1.2 (A:) Lysozyme {Silkworm (Bombyx mori) [Tax 9e-19
d2nwdx1130 d.2.1.2 (X:1-130) Lysozyme {Human (Homo sapiens) [ 7e-32
d2nwdx1130 d.2.1.2 (X:1-130) Lysozyme {Human (Homo sapiens) [ 4e-17
d1yroa1123 d.2.1.2 (A:1-123) alpha-Lactalbumin {Mouse (Mus mu 3e-31
d1yroa1123 d.2.1.2 (A:1-123) alpha-Lactalbumin {Mouse (Mus mu 5e-17
d1b9oa_123 d.2.1.2 (A:) alpha-Lactalbumin {Human (Homo sapien 3e-31
d1b9oa_123 d.2.1.2 (A:) alpha-Lactalbumin {Human (Homo sapien 1e-16
d1hfxa_123 d.2.1.2 (A:) alpha-Lactalbumin {Guinea pig (Cavia 5e-31
d1hfxa_123 d.2.1.2 (A:) alpha-Lactalbumin {Guinea pig (Cavia 1e-16
d2vb1a1129 d.2.1.2 (A:1-129) Lysozyme {Chicken (Gallus gallus 4e-29
d2vb1a1129 d.2.1.2 (A:1-129) Lysozyme {Chicken (Gallus gallus 1e-17
d1lmqa_129 d.2.1.2 (A:) Lysozyme {Rainbow trout (Oncorhynchus 6e-29
d1lmqa_129 d.2.1.2 (A:) Lysozyme {Rainbow trout (Oncorhynchus 1e-16
d1juga_125 d.2.1.2 (A:) Lysozyme {Australian echidna (Tachygl 2e-28
d1juga_125 d.2.1.2 (A:) Lysozyme {Australian echidna (Tachygl 3e-17
d1tpga141 g.3.11.1 (A:51-91) Plasminogen activator (tissue-t 2e-05
d3egfa_53 g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse 3e-05
d3egfa_53 g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse 0.002
d1edmb_39 g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens 7e-05
d1edmb_39 g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens 1e-04
d2c4fl137 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrof 1e-04
d2c4fl137 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrof 2e-04
d1xkba139 g.3.11.1 (A:48-86) Factor X, N-terminal module {Hu 1e-04
d1xkba139 g.3.11.1 (A:48-86) Factor X, N-terminal module {Hu 2e-04
d2vj3a142 g.3.11.1 (A:411-452) Neurogenic locus notch homolo 1e-04
d2vj3a142 g.3.11.1 (A:411-452) Neurogenic locus notch homolo 0.003
d1nqlb_48 g.3.11.1 (B:) Epidermal growth factor, EGF {Human 2e-04
d2vj3a239 g.3.11.1 (A:453-491) Neurogenic locus notch homolo 2e-04
d2vj3a239 g.3.11.1 (A:453-491) Neurogenic locus notch homolo 2e-04
d2vj3a335 g.3.11.1 (A:492-526) Neurogenic locus notch homolo 2e-04
d2vj3a335 g.3.11.1 (A:492-526) Neurogenic locus notch homolo 3e-04
d1g1sa240 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human 4e-04
d1g1sa240 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human 0.002
d1g1ta239 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human 7e-04
d1g1ta239 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human 0.002
d1cvua241 g.3.11.1 (A:33-73) Prostaglandin H2 synthase-1, EG 0.001
d1q4ga242 g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EG 0.002
>d1qqya_ d.2.1.2 (A:) Lysozyme {Dog (Canis familiaris), milk [TaxId: 9615]} Length = 130 Back     information, alignment and structure

class: Alpha and beta proteins (a+b)
fold: Lysozyme-like
superfamily: Lysozyme-like
family: C-type lysozyme
domain: Lysozyme
species: Dog (Canis familiaris), milk [TaxId: 9615]
 Score =  121 bits (305), Expect = 5e-33
 Identities = 47/129 (36%), Positives = 67/129 (51%), Gaps = 10/129 (7%)

Query: 279 KRFGACELAKFLVRQR--GIARRDVPTWVCIATKESNRNSNARSPKNGNGSRDHGIFQIN 336
           K F  CELA+ L      G     +  WVC+A  ESN N+ A + +N NGS D+GIFQ+N
Sbjct: 2   KIFSKCELARKLKSMGMDGFHGYSLANWVCMAEYESNFNTQAFNGRNSNGSSDYGIFQLN 61

Query: 337 DKYWCTASGP-AGKECHAKCSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTY-HYC 394
            K+WC ++   +   C+  CS F D+NI DD+AC  ++          G  AW  +  +C
Sbjct: 62  SKWWCKSNSHSSANACNIMCSKFLDDNIDDDIACAKRVVKDPN-----GMSAWVAWVKHC 116

Query: 395 NTNSKVSTY 403
                +S Y
Sbjct: 117 K-GKDLSKY 124


>d1qqya_ d.2.1.2 (A:) Lysozyme {Dog (Canis familiaris), milk [TaxId: 9615]} Length = 130 Back     information, alignment and structure
>d1gd6a_ d.2.1.2 (A:) Lysozyme {Silkworm (Bombyx mori) [TaxId: 7091]} Length = 119 Back     information, alignment and structure
>d1gd6a_ d.2.1.2 (A:) Lysozyme {Silkworm (Bombyx mori) [TaxId: 7091]} Length = 119 Back     information, alignment and structure
>d2nwdx1 d.2.1.2 (X:1-130) Lysozyme {Human (Homo sapiens) [TaxId: 9606]} Length = 130 Back     information, alignment and structure
>d2nwdx1 d.2.1.2 (X:1-130) Lysozyme {Human (Homo sapiens) [TaxId: 9606]} Length = 130 Back     information, alignment and structure
>d1yroa1 d.2.1.2 (A:1-123) alpha-Lactalbumin {Mouse (Mus musculus) [TaxId: 10090]} Length = 123 Back     information, alignment and structure
>d1yroa1 d.2.1.2 (A:1-123) alpha-Lactalbumin {Mouse (Mus musculus) [TaxId: 10090]} Length = 123 Back     information, alignment and structure
>d1b9oa_ d.2.1.2 (A:) alpha-Lactalbumin {Human (Homo sapiens) [TaxId: 9606]} Length = 123 Back     information, alignment and structure
>d1b9oa_ d.2.1.2 (A:) alpha-Lactalbumin {Human (Homo sapiens) [TaxId: 9606]} Length = 123 Back     information, alignment and structure
>d1hfxa_ d.2.1.2 (A:) alpha-Lactalbumin {Guinea pig (Cavia porcellus) [TaxId: 10141]} Length = 123 Back     information, alignment and structure
>d1hfxa_ d.2.1.2 (A:) alpha-Lactalbumin {Guinea pig (Cavia porcellus) [TaxId: 10141]} Length = 123 Back     information, alignment and structure
>d2vb1a1 d.2.1.2 (A:1-129) Lysozyme {Chicken (Gallus gallus) [TaxId: 9031]} Length = 129 Back     information, alignment and structure
>d2vb1a1 d.2.1.2 (A:1-129) Lysozyme {Chicken (Gallus gallus) [TaxId: 9031]} Length = 129 Back     information, alignment and structure
>d1lmqa_ d.2.1.2 (A:) Lysozyme {Rainbow trout (Oncorhynchus mykiss) [TaxId: 8022]} Length = 129 Back     information, alignment and structure
>d1lmqa_ d.2.1.2 (A:) Lysozyme {Rainbow trout (Oncorhynchus mykiss) [TaxId: 8022]} Length = 129 Back     information, alignment and structure
>d1juga_ d.2.1.2 (A:) Lysozyme {Australian echidna (Tachyglossus aculeatus) [TaxId: 9261]} Length = 125 Back     information, alignment and structure
>d1juga_ d.2.1.2 (A:) Lysozyme {Australian echidna (Tachyglossus aculeatus) [TaxId: 9261]} Length = 125 Back     information, alignment and structure
>d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]} Length = 41 Back     information, alignment and structure
>d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} Length = 53 Back     information, alignment and structure
>d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} Length = 53 Back     information, alignment and structure
>d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} Length = 39 Back     information, alignment and structure
>d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} Length = 39 Back     information, alignment and structure
>d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} Length = 37 Back     information, alignment and structure
>d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} Length = 37 Back     information, alignment and structure
>d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} Length = 39 Back     information, alignment and structure
>d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} Length = 39 Back     information, alignment and structure
>d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Length = 42 Back     information, alignment and structure
>d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Length = 42 Back     information, alignment and structure
>d1nqlb_ g.3.11.1 (B:) Epidermal growth factor, EGF {Human (Homo sapiens) [TaxId: 9606]} Length = 48 Back     information, alignment and structure
>d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Length = 39 Back     information, alignment and structure
>d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Length = 39 Back     information, alignment and structure
>d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Length = 35 Back     information, alignment and structure
>d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Length = 35 Back     information, alignment and structure
>d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} Length = 40 Back     information, alignment and structure
>d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} Length = 40 Back     information, alignment and structure
>d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} Length = 39 Back     information, alignment and structure
>d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} Length = 39 Back     information, alignment and structure
>d1cvua2 g.3.11.1 (A:33-73) Prostaglandin H2 synthase-1, EGF-like module {Mouse (Mus musculus) [TaxId: 10090]} Length = 41 Back     information, alignment and structure
>d1q4ga2 g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EGF-like module {Sheep (Ovis aries) [TaxId: 9940]} Length = 42 Back     information, alignment and structure

Homologous Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query769
d1lmqa_129 Lysozyme {Rainbow trout (Oncorhynchus mykiss) [Tax 100.0
d1juga_125 Lysozyme {Australian echidna (Tachyglossus aculeat 100.0
d2vb1a1129 Lysozyme {Chicken (Gallus gallus) [TaxId: 9031]} 100.0
d1qqya_130 Lysozyme {Dog (Canis familiaris), milk [TaxId: 961 100.0
d1b9oa_123 alpha-Lactalbumin {Human (Homo sapiens) [TaxId: 96 100.0
d2nwdx1130 Lysozyme {Human (Homo sapiens) [TaxId: 9606]} 100.0
d1gd6a_119 Lysozyme {Silkworm (Bombyx mori) [TaxId: 7091]} 100.0
d1hfxa_123 alpha-Lactalbumin {Guinea pig (Cavia porcellus) [T 100.0
d1yroa1123 alpha-Lactalbumin {Mouse (Mus musculus) [TaxId: 10 100.0
d2vb1a1129 Lysozyme {Chicken (Gallus gallus) [TaxId: 9031]} 99.96
d1lmqa_129 Lysozyme {Rainbow trout (Oncorhynchus mykiss) [Tax 99.96
d1juga_125 Lysozyme {Australian echidna (Tachyglossus aculeat 99.95
d1qqya_130 Lysozyme {Dog (Canis familiaris), milk [TaxId: 961 99.95
d2nwdx1130 Lysozyme {Human (Homo sapiens) [TaxId: 9606]} 99.95
d1b9oa_123 alpha-Lactalbumin {Human (Homo sapiens) [TaxId: 96 99.94
d1gd6a_119 Lysozyme {Silkworm (Bombyx mori) [TaxId: 7091]} 99.94
d1hfxa_123 alpha-Lactalbumin {Guinea pig (Cavia porcellus) [T 99.93
d1yroa1123 alpha-Lactalbumin {Mouse (Mus musculus) [TaxId: 10 99.93
d1edmb_39 Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 98.59
d2c4fl137 Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} 98.56
d2vj3a239 Neurogenic locus notch homolog protein 1, Notch1 { 98.55
d2vj3a142 Neurogenic locus notch homolog protein 1, Notch1 { 98.48
d2vj3a142 Neurogenic locus notch homolog protein 1, Notch1 { 98.46
d2vj3a239 Neurogenic locus notch homolog protein 1, Notch1 { 98.43
d1edmb_39 Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 98.42
d2vj3a335 Neurogenic locus notch homolog protein 1, Notch1 { 98.42
d2c4fl137 Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} 98.41
d1tpga141 Plasminogen activator (tissue-type), t-PA {Human ( 98.4
d1xkba139 Factor X, N-terminal module {Human (Homo sapiens) 98.37
d1xkba139 Factor X, N-terminal module {Human (Homo sapiens) 98.31
d1g1sa240 E-selectin, EGF-domain {Human (Homo sapiens) [TaxI 98.26
d2vj3a335 Neurogenic locus notch homolog protein 1, Notch1 { 98.25
d1g1ta239 E-selectin, EGF-domain {Human (Homo sapiens) [TaxI 98.17
d1g1ta239 E-selectin, EGF-domain {Human (Homo sapiens) [TaxI 98.15
d1tpga141 Plasminogen activator (tissue-type), t-PA {Human ( 98.08
d1q4ga242 Prostaglandin H2 synthase-1, EGF-like module {Shee 98.01
d1g1sa240 E-selectin, EGF-domain {Human (Homo sapiens) [TaxI 97.98
d1autl148 Activated protein c (autoprothrombin IIa) {Human ( 97.97
d1autl148 Activated protein c (autoprothrombin IIa) {Human ( 97.92
d1cvua241 Prostaglandin H2 synthase-1, EGF-like module {Mous 97.91
d1emoa143 Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} 97.83
d1q4ga242 Prostaglandin H2 synthase-1, EGF-like module {Shee 97.75
d3egfa_53 Epidermal growth factor, EGF {Mouse (Mus musculus) 97.66
d1cvua241 Prostaglandin H2 synthase-1, EGF-like module {Mous 97.62
d1nqlb_48 Epidermal growth factor, EGF {Human (Homo sapiens) 97.62
d1haea_63 Heregulin-alpha, EGF-like domain {Human (Homo sapi 97.61
d1haea_63 Heregulin-alpha, EGF-like domain {Human (Homo sapi 97.6
d1emoa143 Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} 97.52
d3egfa_53 Epidermal growth factor, EGF {Mouse (Mus musculus) 97.52
d1uzka143 Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} 97.41
d1nqlb_48 Epidermal growth factor, EGF {Human (Homo sapiens) 97.38
d1gl4a240 EGF-like domain of nidogen-1 {Mouse (Mus musculus) 97.26
d1lmja144 Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} 97.15
d1dx5i340 Thrombomodulin, different EGF-like domains {Human 97.06
d1lmja242 Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} 97.03
d1lmja144 Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} 96.98
d1uzka243 Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} 96.92
d1uzka243 Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} 96.91
d1i0ua241 Low density lipoprotein (LDL) receptor, different 96.85
d1dx5i340 Thrombomodulin, different EGF-like domains {Human 96.83
d1uzka143 Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} 96.82
d1i0ua241 Low density lipoprotein (LDL) receptor, different 96.75
d1lmja242 Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} 96.66
d1apqa_53 Complement protease C1R {Human (Homo sapiens) [Tax 96.49
d1apqa_53 Complement protease C1R {Human (Homo sapiens) [Tax 96.39
d1szba245 Mannose-binding protein associated serine protease 96.27
d1nt0a345 Mannose-binding protein associated serine protease 96.27
d1gl4a240 EGF-like domain of nidogen-1 {Mouse (Mus musculus) 96.13
d1nt0a345 Mannose-binding protein associated serine protease 95.82
d1ioxa_50 Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606] 95.81
d1szba245 Mannose-binding protein associated serine protease 95.67
d2i9aa140 Plasminogen activator (urokinase-type) {Human (Hom 95.63
d1k36a_46 Epiregulin, EGF-domain {Human (Homo sapiens) [TaxI 95.63
d1k36a_46 Epiregulin, EGF-domain {Human (Homo sapiens) [TaxI 95.59
d1moxc_49 Transforming growth factor alpha {Human (Homo sapi 95.03
d1ioxa_50 Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606] 94.82
d1nzia242 Complement C1S component {Human (Homo sapiens) [Ta 94.8
d3bpse140 Low density lipoprotein (LDL) receptor, different 94.78
d1emoa239 Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} 94.25
d1moxc_49 Transforming growth factor alpha {Human (Homo sapi 94.24
d1nzia242 Complement C1S component {Human (Homo sapiens) [Ta 94.08
d1emoa239 Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} 93.98
d3bpse140 Low density lipoprotein (LDL) receptor, different 93.83
d2i9aa140 Plasminogen activator (urokinase-type) {Human (Hom 92.6
d1xdtr_41 Heparin-binding epidermal growth factor, HBEGF {Hu 91.4
d1xsfa186 Probable resuscitation-promoting factor RpfB {Myco 91.23
d1gbsa_185 Lysozyme {Australian black swan (Cygnus atratus) [ 90.15
d1kloa155 Laminin gamma1 chain {Mouse (Mus musculus) [TaxId: 89.62
d1autl250 Activated protein c (autoprothrombin IIa) {Human ( 85.65
d1xdtr_41 Heparin-binding epidermal growth factor, HBEGF {Hu 85.27
d1autl250 Activated protein c (autoprothrombin IIa) {Human ( 85.21
d2p3ua151 Factor X, N-terminal module {Human (Homo sapiens) 83.98
d1kigl_51 Factor X, N-terminal module {Cow (Bos taurus) [Tax 83.84
d2p3ua151 Factor X, N-terminal module {Human (Homo sapiens) 81.81
d1qsaa2168 70 kDa soluble lytic transglycosylase, SLT70 {Esch 81.44
>d1lmqa_ d.2.1.2 (A:) Lysozyme {Rainbow trout (Oncorhynchus mykiss) [TaxId: 8022]} Back     information, alignment and structure
class: Alpha and beta proteins (a+b)
fold: Lysozyme-like
superfamily: Lysozyme-like
family: C-type lysozyme
domain: Lysozyme
species: Rainbow trout (Oncorhynchus mykiss) [TaxId: 8022]
Probab=100.00  E-value=4.8e-49  Score=365.14  Aligned_cols=124  Identities=32%  Similarity=0.710  Sum_probs=115.0

Q ss_pred             eeecchHHHHHHHHh--cCCCCCCcccceEeeccccCCCcccccCCCCCCCceeeeeeeccccccCCCCCC--ccccccc
Q psy9686         279 KRFGACELAKFLVRQ--RGIARRDVPTWVCIATKESNRNSNARSPKNGNGSRDHGIFQINDKYWCTASGPA--GKECHAK  354 (769)
Q Consensus       279 k~~~rCela~~l~~~--~g~~~~~l~~wvCla~~eS~~~t~a~~~~~~~gs~~yGifQIn~~~WC~~~~~~--~~~C~~~  354 (769)
                      |||+|||||++|++.  +|||+++|++|||||+|||+|||+|+++ |.|||+||||||||++|||++++++  +|.|+|+
T Consensus         1 Ki~~rCeLAr~L~~~gl~gf~~~~l~~WvCla~~ES~~nT~a~~~-n~~gS~dyGiFQIn~~~WC~~~~~~~~~N~C~i~   79 (129)
T d1lmqa_           1 KVYDRCELARALKASGMDGYAGNSLPNWVCLSKWESSYNTQATNR-NTDGSTDYGIFQINSRYWCDDGRTPGAKNVCGIR   79 (129)
T ss_dssp             CBCCHHHHHHHHHHTTCTTBTTBCHHHHHHHHHHHHTTBTTCEEE-CTTSCEEETTTTEETTTSCBCSCCTTCCCTTCSB
T ss_pred             CcccHhHHHHHHHHcCCcCCChhhHHHHHHHHHHhccCccccccc-CCCCCCCcceeeecchhcccCCCCCCCCCCCCCc
Confidence            799999999999985  3579999999999999999999999997 6799999999999999999987654  6899999


Q ss_pred             cccccCCChhHHHHHHHHHHhcccccccCcccccccCc-cccCCCCCccccccCCc
Q psy9686         355 CSSFEDNNITDDVACVVKIHSQTQRARGNGFQAWSTYH-YCNTNSKVSTYDHADDM  409 (769)
Q Consensus       355 C~~ll~~di~~~i~Cak~i~~~~~~~~~~G~~aW~~w~-~C~g~~~l~~~~~~~~~  409 (769)
                      |++||||||+|||+|||+|+.++     +||+||++|+ +|+|+ +|+.|...|++
T Consensus        80 C~~Ll~ddI~ddi~CAkkIv~~~-----~G~~AW~~w~~~C~g~-~L~~~i~~C~l  129 (129)
T d1lmqa_          80 CSQLLTDDLTVAIRCAKRVVLDP-----NGIGAWVAWRLHCQNQ-DLRSYVAGCGV  129 (129)
T ss_dssp             GGGGSSSSCHHHHHHHHHHTTST-----TGGGGCHHHHHHTTTS-CCGGGTTTSCC
T ss_pred             HHHHcCCCcHHHHHHHHHHHhcc-----cCcchhHHHHHHcCCC-ChHHHHhcCCC
Confidence            99999999999999999999886     8999999999 99996 99999887764



>d1juga_ d.2.1.2 (A:) Lysozyme {Australian echidna (Tachyglossus aculeatus) [TaxId: 9261]} Back     information, alignment and structure
>d2vb1a1 d.2.1.2 (A:1-129) Lysozyme {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure
>d1qqya_ d.2.1.2 (A:) Lysozyme {Dog (Canis familiaris), milk [TaxId: 9615]} Back     information, alignment and structure
>d1b9oa_ d.2.1.2 (A:) alpha-Lactalbumin {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2nwdx1 d.2.1.2 (X:1-130) Lysozyme {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1gd6a_ d.2.1.2 (A:) Lysozyme {Silkworm (Bombyx mori) [TaxId: 7091]} Back     information, alignment and structure
>d1hfxa_ d.2.1.2 (A:) alpha-Lactalbumin {Guinea pig (Cavia porcellus) [TaxId: 10141]} Back     information, alignment and structure
>d1yroa1 d.2.1.2 (A:1-123) alpha-Lactalbumin {Mouse (Mus musculus) [TaxId: 10090]} Back     information, alignment and structure
>d2vb1a1 d.2.1.2 (A:1-129) Lysozyme {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure
>d1lmqa_ d.2.1.2 (A:) Lysozyme {Rainbow trout (Oncorhynchus mykiss) [TaxId: 8022]} Back     information, alignment and structure
>d1juga_ d.2.1.2 (A:) Lysozyme {Australian echidna (Tachyglossus aculeatus) [TaxId: 9261]} Back     information, alignment and structure
>d1qqya_ d.2.1.2 (A:) Lysozyme {Dog (Canis familiaris), milk [TaxId: 9615]} Back     information, alignment and structure
>d2nwdx1 d.2.1.2 (X:1-130) Lysozyme {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1b9oa_ d.2.1.2 (A:) alpha-Lactalbumin {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1gd6a_ d.2.1.2 (A:) Lysozyme {Silkworm (Bombyx mori) [TaxId: 7091]} Back     information, alignment and structure
>d1hfxa_ d.2.1.2 (A:) alpha-Lactalbumin {Guinea pig (Cavia porcellus) [TaxId: 10141]} Back     information, alignment and structure
>d1yroa1 d.2.1.2 (A:1-123) alpha-Lactalbumin {Mouse (Mus musculus) [TaxId: 10090]} Back     information, alignment and structure
>d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} Back     information, alignment and structure
>d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} Back     information, alignment and structure
>d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1q4ga2 g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EGF-like module {Sheep (Ovis aries) [TaxId: 9940]} Back     information, alignment and structure
>d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1cvua2 g.3.11.1 (A:33-73) Prostaglandin H2 synthase-1, EGF-like module {Mouse (Mus musculus) [TaxId: 10090]} Back     information, alignment and structure
>d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1q4ga2 g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EGF-like module {Sheep (Ovis aries) [TaxId: 9940]} Back     information, alignment and structure
>d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} Back     information, alignment and structure
>d1cvua2 g.3.11.1 (A:33-73) Prostaglandin H2 synthase-1, EGF-like module {Mouse (Mus musculus) [TaxId: 10090]} Back     information, alignment and structure
>d1nqlb_ g.3.11.1 (B:) Epidermal growth factor, EGF {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1haea_ g.3.11.1 (A:) Heregulin-alpha, EGF-like domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1haea_ g.3.11.1 (A:) Heregulin-alpha, EGF-like domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} Back     information, alignment and structure
>d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1nqlb_ g.3.11.1 (B:) Epidermal growth factor, EGF {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} Back     information, alignment and structure
>d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1szba2 g.3.11.1 (A:124-168) Mannose-binding protein associated serine protease 2, MASP2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1nt0a3 g.3.11.1 (A:120-164) Mannose-binding protein associated serine protease 2, MASP2 {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} Back     information, alignment and structure
>d1nt0a3 g.3.11.1 (A:120-164) Mannose-binding protein associated serine protease 2, MASP2 {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1ioxa_ g.3.11.1 (A:) Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1szba2 g.3.11.1 (A:124-168) Mannose-binding protein associated serine protease 2, MASP2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2i9aa1 g.3.11.1 (A:10-49) Plasminogen activator (urokinase-type) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1k36a_ g.3.11.1 (A:) Epiregulin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1k36a_ g.3.11.1 (A:) Epiregulin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1moxc_ g.3.11.1 (C:) Transforming growth factor alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1ioxa_ g.3.11.1 (A:) Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1nzia2 g.3.11.1 (A:118-159) Complement C1S component {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d3bpse1 g.3.11.1 (E:293-332) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1moxc_ g.3.11.1 (C:) Transforming growth factor alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1nzia2 g.3.11.1 (A:118-159) Complement C1S component {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d3bpse1 g.3.11.1 (E:293-332) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2i9aa1 g.3.11.1 (A:10-49) Plasminogen activator (urokinase-type) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1xdtr_ g.3.11.1 (R:) Heparin-binding epidermal growth factor, HBEGF {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1xsfa1 d.2.1.8 (A:23-108) Probable resuscitation-promoting factor RpfB {Mycobacterium tuberculosis [TaxId: 1773]} Back     information, alignment and structure
>d1gbsa_ d.2.1.5 (A:) Lysozyme {Australian black swan (Cygnus atratus) [TaxId: 8868]} Back     information, alignment and structure
>d1kloa1 g.3.11.2 (A:11-65) Laminin gamma1 chain {Mouse (Mus musculus) [TaxId: 10090]} Back     information, alignment and structure
>d1autl2 g.3.11.1 (L:97-146) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1xdtr_ g.3.11.1 (R:) Heparin-binding epidermal growth factor, HBEGF {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1autl2 g.3.11.1 (L:97-146) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2p3ua1 g.3.11.1 (A:87-137) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1kigl_ g.3.11.1 (L:) Factor X, N-terminal module {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d2p3ua1 g.3.11.1 (A:87-137) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1qsaa2 d.2.1.6 (A:451-618) 70 kDa soluble lytic transglycosylase, SLT70 {Escherichia coli [TaxId: 562]} Back     information, alignment and structure